JPWO2019236567A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019236567A5 JPWO2019236567A5 JP2020567774A JP2020567774A JPWO2019236567A5 JP WO2019236567 A5 JPWO2019236567 A5 JP WO2019236567A5 JP 2020567774 A JP2020567774 A JP 2020567774A JP 2020567774 A JP2020567774 A JP 2020567774A JP WO2019236567 A5 JPWO2019236567 A5 JP WO2019236567A5
- Authority
- JP
- Japan
- Prior art keywords
- moiety
- peptidase
- drug conjugate
- binder
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091005771 Peptidases Proteins 0.000 claims description 454
- 239000003814 drug Substances 0.000 claims description 183
- 210000004027 cells Anatomy 0.000 claims description 178
- 241000282414 Homo sapiens Species 0.000 claims description 151
- 102000004169 proteins and genes Human genes 0.000 claims description 151
- 108090000623 proteins and genes Proteins 0.000 claims description 151
- 235000018102 proteins Nutrition 0.000 claims description 147
- 230000027455 binding Effects 0.000 claims description 126
- 229940079593 drugs Drugs 0.000 claims description 117
- 229920001184 polypeptide Polymers 0.000 claims description 102
- 206010028980 Neoplasm Diseases 0.000 claims description 79
- -1 OX40-L Proteins 0.000 claims description 78
- 102000004965 antibodies Human genes 0.000 claims description 61
- 108090001123 antibodies Proteins 0.000 claims description 61
- 125000000539 amino acid group Chemical group 0.000 claims description 59
- 239000011230 binding agent Substances 0.000 claims description 55
- 230000002401 inhibitory effect Effects 0.000 claims description 55
- 239000000556 agonist Substances 0.000 claims description 54
- 230000036328 Free drug Effects 0.000 claims description 50
- 201000011510 cancer Diseases 0.000 claims description 49
- MTCFGRXMJLQNBG-REOHCLBHSA-N L-serine Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 48
- 239000004365 Protease Substances 0.000 claims description 47
- 239000000758 substrate Substances 0.000 claims description 46
- 210000001519 tissues Anatomy 0.000 claims description 46
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 45
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 45
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 43
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 43
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 43
- 125000005647 linker group Chemical group 0.000 claims description 42
- 102000004190 Enzymes Human genes 0.000 claims description 41
- 108090000790 Enzymes Proteins 0.000 claims description 41
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 41
- 239000003112 inhibitor Substances 0.000 claims description 36
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims description 35
- 229940088598 Enzyme Drugs 0.000 claims description 33
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 31
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims description 30
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 28
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 28
- 102100009984 FAP Human genes 0.000 claims description 23
- 108010072257 fibroblast activation protein alpha Proteins 0.000 claims description 23
- 108020001507 fusion proteins Proteins 0.000 claims description 22
- 102000037240 fusion proteins Human genes 0.000 claims description 22
- 239000000427 antigen Substances 0.000 claims description 21
- 102000038129 antigens Human genes 0.000 claims description 21
- 108091007172 antigens Proteins 0.000 claims description 21
- 102000005962 receptors Human genes 0.000 claims description 19
- 108020003175 receptors Proteins 0.000 claims description 19
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 18
- 230000001225 therapeutic Effects 0.000 claims description 18
- 238000003776 cleavage reaction Methods 0.000 claims description 17
- 102100007290 CD274 Human genes 0.000 claims description 16
- 101710012053 CD274 Proteins 0.000 claims description 16
- 102100012456 DPP8 Human genes 0.000 claims description 16
- 101700073826 DPP8 Proteins 0.000 claims description 16
- 102100012457 DPP9 Human genes 0.000 claims description 16
- 101700080548 DPP9 Proteins 0.000 claims description 16
- 206010000880 Acute myeloid leukaemia Diseases 0.000 claims description 15
- 235000018417 cysteine Nutrition 0.000 claims description 15
- 230000000144 pharmacologic effect Effects 0.000 claims description 14
- 210000004881 tumor cells Anatomy 0.000 claims description 14
- 210000001744 T-Lymphocytes Anatomy 0.000 claims description 13
- 210000002540 Macrophages Anatomy 0.000 claims description 12
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims description 11
- 125000004122 cyclic group Chemical group 0.000 claims description 11
- 230000028993 immune response Effects 0.000 claims description 11
- 230000036499 Half live Effects 0.000 claims description 10
- 230000003834 intracellular Effects 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 10
- 150000003573 thiols Chemical class 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 230000003308 immunostimulating Effects 0.000 claims description 9
- 239000003446 ligand Substances 0.000 claims description 9
- 230000005012 migration Effects 0.000 claims description 9
- 238000007799 mixed lymphocyte reaction Methods 0.000 claims description 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 8
- 229940110715 ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS Drugs 0.000 claims description 8
- 102100006355 TLR7 Human genes 0.000 claims description 8
- 101700075266 TLR7 Proteins 0.000 claims description 8
- 229940019336 antithrombotic Enzymes Drugs 0.000 claims description 8
- 210000002950 fibroblast Anatomy 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- 229940020899 hematological Enzymes Drugs 0.000 claims description 8
- 230000003993 interaction Effects 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 230000001629 suppression Effects 0.000 claims description 8
- 201000001845 syndromic X-linked intellectual disability Snyder type Diseases 0.000 claims description 8
- 102100005310 CTLA4 Human genes 0.000 claims description 7
- 101700054183 CTLA4 Proteins 0.000 claims description 7
- 102100013885 DDX58 Human genes 0.000 claims description 7
- 101700064525 DDX58 Proteins 0.000 claims description 7
- 108010002350 Interleukin-2 Proteins 0.000 claims description 7
- 102000000588 Interleukin-2 Human genes 0.000 claims description 7
- 108090000028 MMP12 Proteins 0.000 claims description 7
- 230000002238 attenuated Effects 0.000 claims description 7
- 238000004166 bioassay Methods 0.000 claims description 7
- 150000002430 hydrocarbons Chemical class 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 101700028524 DID Proteins 0.000 claims description 6
- 210000001723 Extracellular Space Anatomy 0.000 claims description 6
- 239000012271 PD-L1 inhibitor Substances 0.000 claims description 6
- 229940121656 PD-L1 inhibitors Drugs 0.000 claims description 6
- 102100008790 TNFRSF14 Human genes 0.000 claims description 6
- 101700072533 VM2 Proteins 0.000 claims description 6
- 230000003042 antagnostic Effects 0.000 claims description 6
- 239000005557 antagonist Substances 0.000 claims description 6
- 239000002955 immunomodulating agent Substances 0.000 claims description 6
- 230000002584 immunomodulator Effects 0.000 claims description 6
- 229940121354 immunomodulators Drugs 0.000 claims description 6
- 230000001506 immunosuppresive Effects 0.000 claims description 6
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- NKCXQMYPWXSLIZ-PSRDDEIFSA-N (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-m Chemical compound O=C([C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O NKCXQMYPWXSLIZ-PSRDDEIFSA-N 0.000 claims description 5
- 210000003719 B-Lymphocytes Anatomy 0.000 claims description 5
- 102100009333 BTLA Human genes 0.000 claims description 5
- 101700047069 BTLA Proteins 0.000 claims description 5
- 101710039069 CD160 Proteins 0.000 claims description 5
- 102100014174 CD160 Human genes 0.000 claims description 5
- 210000004443 Dendritic Cells Anatomy 0.000 claims description 5
- 102100017213 LAG3 Human genes 0.000 claims description 5
- 108060004270 LAG3 Proteins 0.000 claims description 5
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims description 5
- 102100006047 TIGIT Human genes 0.000 claims description 5
- 101700052319 TIGIT Proteins 0.000 claims description 5
- 101710038603 TNFRSF18 Proteins 0.000 claims description 5
- 102100003096 TNFRSF18 Human genes 0.000 claims description 5
- 101710040448 TNFRSF4 Proteins 0.000 claims description 5
- 102100013135 TNFRSF4 Human genes 0.000 claims description 5
- 108090000190 Thrombin Proteins 0.000 claims description 5
- 238000009825 accumulation Methods 0.000 claims description 5
- 108091006028 chimera Proteins 0.000 claims description 5
- 101700084791 eprA1 Proteins 0.000 claims description 5
- 101700026663 expR Proteins 0.000 claims description 5
- 239000000411 inducer Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 230000037361 pathway Effects 0.000 claims description 5
- 239000000546 pharmaceutic aid Substances 0.000 claims description 5
- 230000003248 secreting Effects 0.000 claims description 5
- 230000002269 spontaneous Effects 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- 229960004072 thrombin Drugs 0.000 claims description 5
- 102100001249 ALB Human genes 0.000 claims description 4
- 101710027066 ALB Proteins 0.000 claims description 4
- 101700056583 CD27 Proteins 0.000 claims description 4
- 102100019459 CD27 Human genes 0.000 claims description 4
- 102100019461 CD28 Human genes 0.000 claims description 4
- 101700033362 CD28 Proteins 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- 102000005600 Cathepsins Human genes 0.000 claims description 4
- 108010084457 Cathepsins Proteins 0.000 claims description 4
- 102100003966 ELANE Human genes 0.000 claims description 4
- 102100008658 FN1 Human genes 0.000 claims description 4
- 102100008453 FOLH1 Human genes 0.000 claims description 4
- 230000035693 Fab Effects 0.000 claims description 4
- 108010067306 Fibronectins Proteins 0.000 claims description 4
- 102100016384 HAVCR2 Human genes 0.000 claims description 4
- 101710004393 HAVCR2 Proteins 0.000 claims description 4
- 210000004692 Intercellular Junctions Anatomy 0.000 claims description 4
- 102000003729 Neprilysin Human genes 0.000 claims description 4
- 102100007289 PDCD1LG2 Human genes 0.000 claims description 4
- 101710011976 PDCD1LG2 Proteins 0.000 claims description 4
- 102100016187 PVR Human genes 0.000 claims description 4
- 102100009537 TNFRSF9 Human genes 0.000 claims description 4
- 101710040535 TNFRSF9 Proteins 0.000 claims description 4
- 102000004338 Transferrin Human genes 0.000 claims description 4
- 108090000901 Transferrin Proteins 0.000 claims description 4
- 102100015314 VSIR Human genes 0.000 claims description 4
- 101710036075 VSIR Proteins 0.000 claims description 4
- 230000004663 cell proliferation Effects 0.000 claims description 4
- 230000037320 fibronectin Effects 0.000 claims description 4
- 230000002147 killing Effects 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 4
- 150000003384 small molecules Chemical class 0.000 claims description 4
- 239000012581 transferrin Substances 0.000 claims description 4
- 229940064734 Aminobenzoate Drugs 0.000 claims description 3
- 102100019456 CD276 Human genes 0.000 claims description 3
- 101700015421 CD276 Proteins 0.000 claims description 3
- 101710040446 CD40 Proteins 0.000 claims description 3
- 102100013137 CD40 Human genes 0.000 claims description 3
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 claims description 3
- 101700036477 FOLH1 Proteins 0.000 claims description 3
- 102100003900 GEM Human genes 0.000 claims description 3
- 108060003143 GEM Proteins 0.000 claims description 3
- 210000003714 Granulocytes Anatomy 0.000 claims description 3
- 210000000822 Killer Cells, Natural Anatomy 0.000 claims description 3
- 102100004651 LGALS9 Human genes 0.000 claims description 3
- 108010028275 Leukocyte Elastase Proteins 0.000 claims description 3
- 210000001165 Lymph Nodes Anatomy 0.000 claims description 3
- 101710005673 NECTIN2 Proteins 0.000 claims description 3
- 101700008337 PSMA Proteins 0.000 claims description 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 3
- 108060007796 SPATA2 Proteins 0.000 claims description 3
- 102100019633 ST14 Human genes 0.000 claims description 3
- 102000012479 Serine Proteases Human genes 0.000 claims description 3
- 108010022999 Serine Proteases Proteins 0.000 claims description 3
- 102100012088 TLR3 Human genes 0.000 claims description 3
- 101700023131 TLR3 Proteins 0.000 claims description 3
- 102000008235 Toll-Like Receptor 9 Human genes 0.000 claims description 3
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 claims description 3
- 102100014952 VTCN1 Human genes 0.000 claims description 3
- 101700068327 VTCN1 Proteins 0.000 claims description 3
- XXXHSQBVHSJQKS-UHFFFAOYSA-N amino benzoate Chemical compound NOC(=O)C1=CC=CC=C1 XXXHSQBVHSJQKS-UHFFFAOYSA-N 0.000 claims description 3
- 102000031064 asparaginylendopeptidase Human genes 0.000 claims description 3
- 108010055066 asparaginylendopeptidase Proteins 0.000 claims description 3
- 125000002619 bicyclic group Chemical group 0.000 claims description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 3
- 230000000981 bystander Effects 0.000 claims description 3
- 230000004656 cell transport Effects 0.000 claims description 3
- 230000001472 cytotoxic Effects 0.000 claims description 3
- 231100000433 cytotoxic Toxicity 0.000 claims description 3
- HKXJWBUUDLVWML-UHFFFAOYSA-N methyl cyclohexanecarboxylate;pyrrole-2,5-dione Chemical compound O=C1NC(=O)C=C1.COC(=O)C1CCCCC1 HKXJWBUUDLVWML-UHFFFAOYSA-N 0.000 claims description 3
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- 230000036593 pulmonary vascular resistance Effects 0.000 claims description 3
- 101710044770 sll1951 Proteins 0.000 claims description 3
- 102000002938 thrombospondin family Human genes 0.000 claims description 3
- 108060008245 thrombospondin family Proteins 0.000 claims description 3
- PQEJXGNZBLONLG-XJDOXCRVSA-N (2R)-2-amino-3-[1-[3-[2-[4-[1,3-bis(2-methoxyethylcarbamoyloxy)propan-2-yloxy]butanoylamino]ethylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid Chemical compound COCCNC(=O)OCC(COC(=O)NCCOC)OCCCC(=O)NCCNC(=O)CCN1C(=O)CC(SC[C@H](N)C(O)=O)C1=O PQEJXGNZBLONLG-XJDOXCRVSA-N 0.000 claims description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims description 2
- 102100007702 BTN1A1 Human genes 0.000 claims description 2
- 101710043923 BTN1A1 Proteins 0.000 claims description 2
- 102100015496 BTN2A2 Human genes 0.000 claims description 2
- 101710012271 BTN2A2 Proteins 0.000 claims description 2
- 102100015491 BTN3A2 Human genes 0.000 claims description 2
- 101710012706 BTN3A2 Proteins 0.000 claims description 2
- 102100014180 BTNL2 Human genes 0.000 claims description 2
- 101700021769 BTNL2 Proteins 0.000 claims description 2
- 102100003729 CD40LG Human genes 0.000 claims description 2
- 101710003804 CD40LG Proteins 0.000 claims description 2
- 102100005175 CSF1R Human genes 0.000 claims description 2
- 101700063802 CSF1R Proteins 0.000 claims description 2
- 102000005927 Cysteine Proteases Human genes 0.000 claims description 2
- 108010005843 Cysteine Proteases Proteins 0.000 claims description 2
- 210000003979 Eosinophils Anatomy 0.000 claims description 2
- 101710042195 GAL9 Proteins 0.000 claims description 2
- 102100014733 ICOSLG Human genes 0.000 claims description 2
- 101710039212 ICOSLG Proteins 0.000 claims description 2
- 101700025933 IR07 Proteins 0.000 claims description 2
- 210000004322 M2 macrophage Anatomy 0.000 claims description 2
- 102100019764 PDCD1 Human genes 0.000 claims description 2
- 102000001938 Plasminogen Activators Human genes 0.000 claims description 2
- 108010001014 Plasminogen Activators Proteins 0.000 claims description 2
- 102100002617 TLR1 Human genes 0.000 claims description 2
- 101700068316 TLR1 Proteins 0.000 claims description 2
- 102100012096 TLR2 Human genes 0.000 claims description 2
- 101700064022 TLR2 Proteins 0.000 claims description 2
- 102100012087 TLR4 Human genes 0.000 claims description 2
- 101700022711 TLR4 Proteins 0.000 claims description 2
- 102100006352 TLR5 Human genes 0.000 claims description 2
- 101700025666 TLR5 Proteins 0.000 claims description 2
- 102100006353 TLR6 Human genes 0.000 claims description 2
- 101700030074 TLR6 Proteins 0.000 claims description 2
- 102100006354 TLR8 Human genes 0.000 claims description 2
- 101700071772 TLR8 Proteins 0.000 claims description 2
- 102100003084 TNFSF9 Human genes 0.000 claims description 2
- 101710025686 TNFSF9 Proteins 0.000 claims description 2
- 229960005356 Urokinase Drugs 0.000 claims description 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims description 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims description 2
- 229940050528 albumin Drugs 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 230000000903 blocking Effects 0.000 claims description 2
- 210000003690 classically activated macrophage Anatomy 0.000 claims description 2
- 229960002986 dinoprostone Drugs 0.000 claims description 2
- 230000002255 enzymatic Effects 0.000 claims description 2
- 210000003289 regulatory T cell Anatomy 0.000 claims description 2
- 231100000331 toxic Toxicity 0.000 claims description 2
- 230000002588 toxic Effects 0.000 claims description 2
- 102000033147 ERVK-25 Human genes 0.000 claims 9
- 101700017647 CD33 Proteins 0.000 claims 2
- 102100016493 CD33 Human genes 0.000 claims 2
- 108009000330 Matrix Metalloproteinases Proteins 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 102000002689 toll-like receptors Human genes 0.000 claims 2
- 108020000411 toll-like receptors Proteins 0.000 claims 2
- 210000002889 Endothelial Cells Anatomy 0.000 claims 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 claims 1
- 102100013504 RPL17 Human genes 0.000 claims 1
- XZAZIVPAQXCKSW-UHFFFAOYSA-N [N-(hydroxymethyl)anilino]methanol Chemical compound OCN(CO)C1=CC=CC=C1 XZAZIVPAQXCKSW-UHFFFAOYSA-N 0.000 claims 1
- 230000014828 interferon-gamma production Effects 0.000 claims 1
- 108010091175 matriptase Proteins 0.000 claims 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-M valerate Chemical compound CCCCC([O-])=O NQPDZGIKBAWPEJ-UHFFFAOYSA-M 0.000 claims 1
- 102000035443 Peptidases Human genes 0.000 description 445
- 235000019833 protease Nutrition 0.000 description 434
- 235000001014 amino acid Nutrition 0.000 description 57
- 150000001413 amino acids Chemical class 0.000 description 56
- 210000000349 Chromosomes Anatomy 0.000 description 33
- 229940021015 I.V. solution additive Amino Acids Drugs 0.000 description 33
- 241001430294 unidentified retrovirus Species 0.000 description 33
- 125000003118 aryl group Chemical group 0.000 description 30
- 230000002378 acidificating Effects 0.000 description 29
- 102000033207 ERVK-9 Human genes 0.000 description 28
- 101710003629 ERVK-9 Proteins 0.000 description 28
- 230000001264 neutralization Effects 0.000 description 27
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 24
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 125000000217 alkyl group Chemical group 0.000 description 21
- 230000004044 response Effects 0.000 description 19
- 201000010099 disease Diseases 0.000 description 18
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 17
- 102000006640 EC 2.3.2.2 Human genes 0.000 description 15
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 15
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 108010050095 PT-100 dipeptide Proteins 0.000 description 15
- 125000001424 substituent group Chemical group 0.000 description 15
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 14
- 108020004206 EC 2.3.2.2 Proteins 0.000 description 13
- 102000018358 Immunoglobulins Human genes 0.000 description 13
- 108060003951 Immunoglobulins Proteins 0.000 description 13
- 101710033528 TEPSIN Proteins 0.000 description 13
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 13
- 201000009030 carcinoma Diseases 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 125000000623 heterocyclic group Chemical group 0.000 description 13
- 229960001153 serine Drugs 0.000 description 13
- 235000004400 serine Nutrition 0.000 description 13
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 229940088597 Hormone Drugs 0.000 description 11
- 101700086543 M23B Proteins 0.000 description 11
- 239000005556 hormone Substances 0.000 description 11
- 238000006467 substitution reaction Methods 0.000 description 11
- 229960002433 Cysteine Drugs 0.000 description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 10
- FKCMADOPPWWGNZ-YUMQZZPRSA-N [(2R)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O FKCMADOPPWWGNZ-YUMQZZPRSA-N 0.000 description 10
- 230000004913 activation Effects 0.000 description 10
- 125000001931 aliphatic group Chemical group 0.000 description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 9
- 230000004064 dysfunction Effects 0.000 description 9
- 230000002708 enhancing Effects 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 125000001072 heteroaryl group Chemical group 0.000 description 9
- 125000005842 heteroatoms Chemical group 0.000 description 9
- 238000000338 in vitro Methods 0.000 description 9
- 125000004429 atoms Chemical group 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 125000004432 carbon atoms Chemical group C* 0.000 description 8
- 230000001413 cellular Effects 0.000 description 8
- 230000000875 corresponding Effects 0.000 description 8
- 125000000753 cycloalkyl group Chemical group 0.000 description 8
- 230000001965 increased Effects 0.000 description 8
- SIKJAQJRHWYJAI-UHFFFAOYSA-N indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- AOJJSUZBOXZQNB-TZSSRYMLSA-N ADRIAMYCIN Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 7
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 7
- 229960004679 Doxorubicin Drugs 0.000 description 7
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 7
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 7
- 230000003197 catalytic Effects 0.000 description 7
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 7
- 229940121650 immune-checkpoint protein inhibitors Drugs 0.000 description 7
- 230000002194 synthesizing Effects 0.000 description 7
- 230000004614 tumor growth Effects 0.000 description 7
- 206010006187 Breast cancer Diseases 0.000 description 6
- 102000004157 Hydrolases Human genes 0.000 description 6
- 108090000604 Hydrolases Proteins 0.000 description 6
- 229960000310 ISOLEUCINE Drugs 0.000 description 6
- 102100019442 ITGAL Human genes 0.000 description 6
- 239000004473 Threonine Substances 0.000 description 6
- 108090000848 Ubiquitin Proteins 0.000 description 6
- 102400000757 Ubiquitin Human genes 0.000 description 6
- 125000003342 alkenyl group Chemical group 0.000 description 6
- 125000004414 alkyl thio group Chemical group 0.000 description 6
- 125000004093 cyano group Chemical group *C#N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 210000002865 immune cell Anatomy 0.000 description 6
- 235000014705 isoleucine Nutrition 0.000 description 6
- 230000003902 lesions Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 6
- 229960002898 threonine Drugs 0.000 description 6
- 235000008521 threonine Nutrition 0.000 description 6
- 229960003767 Alanine Drugs 0.000 description 5
- 229920001405 Coding region Polymers 0.000 description 5
- 102000003688 G-protein coupled receptors Human genes 0.000 description 5
- 108090000045 G-protein coupled receptors Proteins 0.000 description 5
- 229960002989 Glutamic Acid Drugs 0.000 description 5
- 229960002449 Glycine Drugs 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 5
- 108010064750 Humanized Monoclonal Antibodies Proteins 0.000 description 5
- 102000015434 Humanized Monoclonal Antibodies Human genes 0.000 description 5
- 210000000987 Immune System Anatomy 0.000 description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
- HPJKCIUCZWXJDR-UHFFFAOYSA-N Letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 description 5
- 206010024324 Leukaemias Diseases 0.000 description 5
- 101700060512 MMP2 Proteins 0.000 description 5
- 102100014894 MMP2 Human genes 0.000 description 5
- 229960004452 Methionine Drugs 0.000 description 5
- 229960005190 Phenylalanine Drugs 0.000 description 5
- 102000001400 Tryptase family Human genes 0.000 description 5
- 108060005989 Tryptase family Proteins 0.000 description 5
- 229960004441 Tyrosine Drugs 0.000 description 5
- 229960004528 Vincristine Drugs 0.000 description 5
- 235000004279 alanine Nutrition 0.000 description 5
- 125000000304 alkynyl group Chemical group 0.000 description 5
- 230000000259 anti-tumor Effects 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
- 230000000295 complement Effects 0.000 description 5
- 238000010192 crystallographic characterization Methods 0.000 description 5
- 150000002148 esters Chemical group 0.000 description 5
- 235000013922 glutamic acid Nutrition 0.000 description 5
- 239000004220 glutamic acid Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 5
- 150000002576 ketones Chemical group 0.000 description 5
- 229960003136 leucine Drugs 0.000 description 5
- 235000005772 leucine Nutrition 0.000 description 5
- 235000006109 methionine Nutrition 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 210000000056 organs Anatomy 0.000 description 5
- 235000008729 phenylalanine Nutrition 0.000 description 5
- 239000000651 prodrug Substances 0.000 description 5
- 229940002612 prodrugs Drugs 0.000 description 5
- 230000002829 reduced Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000002459 sustained Effects 0.000 description 5
- 235000002374 tyrosine Nutrition 0.000 description 5
- 229960005486 vaccines Drugs 0.000 description 5
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 5
- CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical class C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 4
- 208000000409 Breast Neoplasms Diseases 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 4
- 102100012353 DPP4 Human genes 0.000 description 4
- 206010011968 Decreased immune responsiveness Diseases 0.000 description 4
- 210000000981 Epithelium Anatomy 0.000 description 4
- 229960002743 Glutamine Drugs 0.000 description 4
- 229960002885 Histidine Drugs 0.000 description 4
- RCINICONZNJXQF-MZXODVADSA-N Intaxel Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 4
- 208000007046 Leukemia, Myeloid, Acute Diseases 0.000 description 4
- 102100007223 MGLL Human genes 0.000 description 4
- 101700027140 MGLL Proteins 0.000 description 4
- 101700019781 MMP1 Proteins 0.000 description 4
- 102100018200 MMP1 Human genes 0.000 description 4
- 101700040359 MMP3 Proteins 0.000 description 4
- 102100014893 MMP3 Human genes 0.000 description 4
- 101700067851 MMP9 Proteins 0.000 description 4
- 102100006844 MMP9 Human genes 0.000 description 4
- 206010027476 Metastasis Diseases 0.000 description 4
- KKZJGLLVHKMTCM-UHFFFAOYSA-N Mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 4
- 229960001156 Mitoxantrone Drugs 0.000 description 4
- 241000699660 Mus musculus Species 0.000 description 4
- 102100016461 PIDD1 Human genes 0.000 description 4
- 101700026154 PIDD1 Proteins 0.000 description 4
- 229960001592 Paclitaxel Drugs 0.000 description 4
- 102100017643 SLAMF1 Human genes 0.000 description 4
- 206010039491 Sarcoma Diseases 0.000 description 4
- 241001522306 Serinus serinus Species 0.000 description 4
- 229960004799 Tryptophan Drugs 0.000 description 4
- 150000001299 aldehydes Chemical group 0.000 description 4
- 125000003710 aryl alkyl group Chemical group 0.000 description 4
- XSCXGOPPNHTWEF-UHFFFAOYSA-N diazenide Chemical group [N-]=N XSCXGOPPNHTWEF-UHFFFAOYSA-N 0.000 description 4
- 201000009910 diseases by infectious agent Diseases 0.000 description 4
- 235000004554 glutamine Nutrition 0.000 description 4
- 235000014304 histidine Nutrition 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 229960003881 letrozole Drugs 0.000 description 4
- 230000003211 malignant Effects 0.000 description 4
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000036961 partial Effects 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical group [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 description 4
- NJRWNWYFPOFDFN-UHFFFAOYSA-L phosphonate(2-) Chemical group [O-][P]([O-])=O NJRWNWYFPOFDFN-UHFFFAOYSA-L 0.000 description 4
- 229920000023 polynucleotide Polymers 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 230000006010 pyroptosis Effects 0.000 description 4
- 230000011664 signaling Effects 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 125000000547 substituted alkyl group Chemical group 0.000 description 4
- 230000004083 survival Effects 0.000 description 4
- 229960004295 valine Drugs 0.000 description 4
- 235000014393 valine Nutrition 0.000 description 4
- 239000004474 valine Substances 0.000 description 4
- ZROHGHOFXNOHSO-BNTLRKBRSA-L (1R,2R)-cyclohexane-1,2-diamine;oxalate;platinum(2+) Chemical compound [H][N]([C@@H]1CCCC[C@H]1[N]1([H])[H])([H])[Pt]11OC(=O)C(=O)O1 ZROHGHOFXNOHSO-BNTLRKBRSA-L 0.000 description 3
- GHASVSINZRGABV-UHFFFAOYSA-N 5-flurouricil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 3
- 102100010284 ADAM17 Human genes 0.000 description 3
- 101710043085 ADAM17 Proteins 0.000 description 3
- 101710043111 ADAM28 Proteins 0.000 description 3
- 108091005658 ADAMTS8 Proteins 0.000 description 3
- 206010000871 Acute monocytic leukaemia Diseases 0.000 description 3
- 108090000915 Aminopeptidases Proteins 0.000 description 3
- 102000004400 Aminopeptidases Human genes 0.000 description 3
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 3
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 3
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 3
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 229960001230 Asparagine Drugs 0.000 description 3
- 229960005261 Aspartic Acid Drugs 0.000 description 3
- 210000000941 Bile Anatomy 0.000 description 3
- 206010005003 Bladder cancer Diseases 0.000 description 3
- 210000000988 Bone and Bones Anatomy 0.000 description 3
- 102100016160 CAD Human genes 0.000 description 3
- 102100008191 CD8A Human genes 0.000 description 3
- 101700054655 CD8A Proteins 0.000 description 3
- 102100006090 CELA3B Human genes 0.000 description 3
- 108010051152 Carboxylesterase Proteins 0.000 description 3
- 102000013392 Carboxylesterase Human genes 0.000 description 3
- 102000005572 Cathepsin A Human genes 0.000 description 3
- 108010059081 Cathepsin A Proteins 0.000 description 3
- 230000037250 Clearance Effects 0.000 description 3
- ACSIXWWBWUQEHA-UHFFFAOYSA-N Clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 description 3
- 108091000127 Dihydroorotase Proteins 0.000 description 3
- 229960002949 Fluorouracil Drugs 0.000 description 3
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 3
- 206010020243 Hodgkin's disease Diseases 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 102100019334 ITGA4 Human genes 0.000 description 3
- 101710006711 ITGA4 Proteins 0.000 description 3
- 102100012155 ITGA6 Human genes 0.000 description 3
- 101710006573 ITGAL Proteins 0.000 description 3
- 102100001475 ITGB2 Human genes 0.000 description 3
- 101710006663 ITGB2 Proteins 0.000 description 3
- 102100011339 KLK3 Human genes 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 3
- 206010025323 Lymphomas Diseases 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 101700081066 MMP11 Proteins 0.000 description 3
- 102100016819 MMP11 Human genes 0.000 description 3
- 102100004961 MMP12 Human genes 0.000 description 3
- 101700084657 MMP13 Proteins 0.000 description 3
- 102100004962 MMP13 Human genes 0.000 description 3
- 102100004965 MMP14 Human genes 0.000 description 3
- 101700056196 MMP14 Proteins 0.000 description 3
- 102100018202 MMP19 Human genes 0.000 description 3
- 101710030790 MMP19 Proteins 0.000 description 3
- 102000009112 Mannose-Binding Lectin Human genes 0.000 description 3
- 108010087870 Mannose-Binding Lectin Proteins 0.000 description 3
- 229920001850 Nucleic acid sequence Polymers 0.000 description 3
- 101700047009 PCSK6 Proteins 0.000 description 3
- 102100003489 PCSK6 Human genes 0.000 description 3
- 210000002381 Plasma Anatomy 0.000 description 3
- 229960002429 Proline Drugs 0.000 description 3
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 3
- 102100017641 SLAMF6 Human genes 0.000 description 3
- 101710030439 SLAMF6 Proteins 0.000 description 3
- 210000001550 Testis Anatomy 0.000 description 3
- FOCVUCIESVLUNU-UHFFFAOYSA-N ThioTEPA Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 3
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 3
- 210000001635 Urinary Tract Anatomy 0.000 description 3
- XRASPMIURGNCCH-UHFFFAOYSA-N Zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000001154 acute Effects 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000000240 adjuvant Effects 0.000 description 3
- 230000000735 allogeneic Effects 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000000890 antigenic Effects 0.000 description 3
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 description 3
- 229960003121 arginine Drugs 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 235000009582 asparagine Nutrition 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- 230000003115 biocidal Effects 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 230000035512 clearance Effects 0.000 description 3
- 201000011231 colorectal cancer Diseases 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 230000001461 cytolytic Effects 0.000 description 3
- 230000001086 cytosolic Effects 0.000 description 3
- 230000003247 decreasing Effects 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical class C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N furane Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001976 improved Effects 0.000 description 3
- 229940079866 intestinal antibiotics Drugs 0.000 description 3
- 229960003646 lysine Drugs 0.000 description 3
- 235000018977 lysine Nutrition 0.000 description 3
- 230000002438 mitochondrial Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000006011 modification reaction Methods 0.000 description 3
- 229960000060 monoclonal antibodies Drugs 0.000 description 3
- 108010045030 monoclonal antibodies Proteins 0.000 description 3
- 102000005614 monoclonal antibodies Human genes 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 3
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 3
- 230000001717 pathogenic Effects 0.000 description 3
- 244000052769 pathogens Species 0.000 description 3
- 125000003367 polycyclic group Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000004481 post-translational protein modification Effects 0.000 description 3
- 230000003389 potentiating Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000013930 proline Nutrition 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000004043 responsiveness Effects 0.000 description 3
- 238000009958 sewing Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 229930003347 taxol Natural products 0.000 description 3
- 229960004276 zoledronic acid Drugs 0.000 description 3
- ADGFNXYXROZUOG-VKHMYHEASA-N (2S)-2-(cyanoamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC#N ADGFNXYXROZUOG-VKHMYHEASA-N 0.000 description 2
- BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N 3-hydroxy-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 229940000681 5-Hydroxytryptophan Drugs 0.000 description 2
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan zwitterion Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 2
- 101710024036 AADAC Proteins 0.000 description 2
- 102100012011 AADAC Human genes 0.000 description 2
- 101710025678 ABHD12B Proteins 0.000 description 2
- 102100004960 ABHD12B Human genes 0.000 description 2
- 102100006013 ABHD14B Human genes 0.000 description 2
- 101710011283 ABHD14B Proteins 0.000 description 2
- 102100011386 ABHD5 Human genes 0.000 description 2
- 101700007844 ABHD5 Proteins 0.000 description 2
- 102100010286 ADAM10 Human genes 0.000 description 2
- 101710043077 ADAM10 Proteins 0.000 description 2
- 102100010288 ADAM12 Human genes 0.000 description 2
- 101710043080 ADAM12 Proteins 0.000 description 2
- 101710043098 ADAM15 Proteins 0.000 description 2
- 101710043108 ADAM20 Proteins 0.000 description 2
- 101710043106 ADAM21 Proteins 0.000 description 2
- 101710043107 ADAM23 Proteins 0.000 description 2
- 102100001917 ADAM28 Human genes 0.000 description 2
- 101710042945 ADAM33 Proteins 0.000 description 2
- 108091005564 ADAMTS18 Proteins 0.000 description 2
- 102100001556 ADGRA3 Human genes 0.000 description 2
- 101710005079 ADGRA3 Proteins 0.000 description 2
- 102100001554 ADGRB2 Human genes 0.000 description 2
- 101710005061 ADGRB2 Proteins 0.000 description 2
- 102100020344 ADGRD1 Human genes 0.000 description 2
- 101710005019 ADGRD1 Proteins 0.000 description 2
- 101710005032 ADGRE5 Proteins 0.000 description 2
- 102100020523 ADGRE5 Human genes 0.000 description 2
- 102100000074 ADGRF3 Human genes 0.000 description 2
- 101710005047 ADGRF3 Proteins 0.000 description 2
- 102100000071 ADGRF5 Human genes 0.000 description 2
- 101710005044 ADGRF5 Proteins 0.000 description 2
- 102100010882 ADGRG1 Human genes 0.000 description 2
- 101710005049 ADGRG1 Proteins 0.000 description 2
- 101710005048 ADGRG2 Proteins 0.000 description 2
- 102100010894 ADGRG3 Human genes 0.000 description 2
- 101710005054 ADGRG3 Proteins 0.000 description 2
- 101710005051 ADGRG5 Proteins 0.000 description 2
- 102100010897 ADGRG6 Human genes 0.000 description 2
- 101710005050 ADGRG6 Proteins 0.000 description 2
- 102100017222 ADGRG7 Human genes 0.000 description 2
- 101710005052 ADGRG7 Proteins 0.000 description 2
- 102100000313 ADGRL4 Human genes 0.000 description 2
- 101710004992 ADGRL4 Proteins 0.000 description 2
- 102100003718 APEH Human genes 0.000 description 2
- 102100001795 ASRGL1 Human genes 0.000 description 2
- 101700042854 ATP23 Proteins 0.000 description 2
- 229960004373 Acetylcholine Drugs 0.000 description 2
- 206010000830 Acute leukaemia Diseases 0.000 description 2
- 208000009956 Adenocarcinoma Diseases 0.000 description 2
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 2
- 108020003076 Amidases Proteins 0.000 description 2
- 102000005922 Amidases Human genes 0.000 description 2
- ROBVIMPUHSLWNV-UHFFFAOYSA-N Aminoglutethimide Chemical compound C=1C=C(N)C=CC=1C1(CC)CCC(=O)NC1=O ROBVIMPUHSLWNV-UHFFFAOYSA-N 0.000 description 2
- 229960003437 Aminoglutethimide Drugs 0.000 description 2
- 102100015650 BACE1 Human genes 0.000 description 2
- 210000004369 Blood Anatomy 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 210000001185 Bone Marrow Anatomy 0.000 description 2
- 210000004556 Brain Anatomy 0.000 description 2
- 102100003814 CASP3 Human genes 0.000 description 2
- 102100014427 CASP4 Human genes 0.000 description 2
- 102100006337 CASP5 Human genes 0.000 description 2
- 102100008990 CASP8 Human genes 0.000 description 2
- 102100000166 CD226 Human genes 0.000 description 2
- 101700022117 CD226 Proteins 0.000 description 2
- 102100019451 CD80 Human genes 0.000 description 2
- 101700080477 CD80 Proteins 0.000 description 2
- 102100014435 CD96 Human genes 0.000 description 2
- 101710026045 CD96 Proteins 0.000 description 2
- 101710026891 CES1 Proteins 0.000 description 2
- 101710026890 CES3 Proteins 0.000 description 2
- 102100001446 CES3 Human genes 0.000 description 2
- 102100003123 CPA4 Human genes 0.000 description 2
- 101710003556 CPA4 Proteins 0.000 description 2
- 102100003774 CPZ Human genes 0.000 description 2
- 102100009031 CTSK Human genes 0.000 description 2
- 102100015376 CTSV Human genes 0.000 description 2
- VSJKWCGYPAHWDS-FQEVSTJZSA-N Camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 2
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N Carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 108010080937 Carboxypeptidases A Proteins 0.000 description 2
- 102000000496 Carboxypeptidases A Human genes 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 102000004046 Caspase 2 Human genes 0.000 description 2
- 108090000552 Caspase 2 Proteins 0.000 description 2
- 108090000397 Caspase 3 Proteins 0.000 description 2
- 102000004018 Caspase 6 Human genes 0.000 description 2
- 108090000425 Caspase 6 Proteins 0.000 description 2
- 102000004041 Caspase 7 Human genes 0.000 description 2
- 108090000567 Caspase 7 Proteins 0.000 description 2
- 108090000538 Caspase 8 Proteins 0.000 description 2
- 102000004039 Caspase 9 Human genes 0.000 description 2
- 108090000566 Caspase 9 Proteins 0.000 description 2
- 102000004068 Caspase-10 Human genes 0.000 description 2
- 108090000572 Caspase-10 Proteins 0.000 description 2
- 102000004958 Caspase-14 Human genes 0.000 description 2
- 108090001132 Caspase-14 Proteins 0.000 description 2
- 108090000267 Cathepsin C Proteins 0.000 description 2
- 102000003902 Cathepsin C Human genes 0.000 description 2
- 210000002421 Cell Wall Anatomy 0.000 description 2
- 101700062655 Ces1d Proteins 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- PSNOPSMXOBPNNV-VVCTWANISA-N Cryptophycin 1 Chemical compound C1=C(Cl)C(OC)=CC=C1C[C@@H]1C(=O)NC[C@@H](C)C(=O)O[C@@H](CC(C)C)C(=O)O[C@H]([C@H](C)[C@@H]2[C@H](O2)C=2C=CC=CC=2)C/C=C/C(=O)N1 PSNOPSMXOBPNNV-VVCTWANISA-N 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- 102000015833 Cystatins Human genes 0.000 description 2
- 108050004038 Cystatins Proteins 0.000 description 2
- 101700028750 DPEP2 Proteins 0.000 description 2
- 101700062901 DPP Proteins 0.000 description 2
- 102100005612 DPP10 Human genes 0.000 description 2
- 101700023262 DPP10 Proteins 0.000 description 2
- 101700039720 DPP4 Proteins 0.000 description 2
- 101700071662 DPP6 Proteins 0.000 description 2
- 102100015578 DPP6 Human genes 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- 101700057458 Drice Proteins 0.000 description 2
- 108030004769 EC 3.4.13.19 Proteins 0.000 description 2
- 108010061216 EC 3.4.19.1 Proteins 0.000 description 2
- 108030003252 EC 3.4.21.108 Proteins 0.000 description 2
- 108010090225 EC 3.4.21.26 Proteins 0.000 description 2
- 108030007201 EC 3.4.21.70 Proteins 0.000 description 2
- 108030007212 EC 3.4.21.79 Proteins 0.000 description 2
- 108030001378 EC 3.4.22.57 Proteins 0.000 description 2
- 108030001379 EC 3.4.22.58 Proteins 0.000 description 2
- 101700066372 ECM38 Proteins 0.000 description 2
- 102100010782 EGFR Human genes 0.000 description 2
- 101700039191 EGFR Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102100016847 ELN Human genes 0.000 description 2
- 101700012715 ELN Proteins 0.000 description 2
- 102100016692 ESR1 Human genes 0.000 description 2
- 102000005593 Endopeptidases Human genes 0.000 description 2
- 108010059378 Endopeptidases Proteins 0.000 description 2
- VJJPUSNTGOMMGY-MRVIYFEKSA-N Etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 2
- 229960005420 Etoposide Drugs 0.000 description 2
- 210000003722 Extracellular Fluid Anatomy 0.000 description 2
- 102100015541 FCGR3A Human genes 0.000 description 2
- 101710044656 FCGR3A Proteins 0.000 description 2
- 101710044657 FCGR3B Proteins 0.000 description 2
- 101700010580 FLO11 Proteins 0.000 description 2
- 101700009480 Fcgr3 Proteins 0.000 description 2
- 108010088842 Fibrinolysin Proteins 0.000 description 2
- 108091006011 G proteins Proteins 0.000 description 2
- 102100003880 GGH Human genes 0.000 description 2
- 101700082072 GGT1 Proteins 0.000 description 2
- 108091000058 GTP-Binding Proteins Proteins 0.000 description 2
- 102000030007 GTP-Binding Proteins Human genes 0.000 description 2
- 102100004391 GZMB Human genes 0.000 description 2
- CHPZKNULDCNCBW-UHFFFAOYSA-N Gallium nitrate Chemical compound [Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O CHPZKNULDCNCBW-UHFFFAOYSA-N 0.000 description 2
- SDUQYLNIPVEERB-QPPQHZFASA-N Gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 2
- 210000004907 Glands Anatomy 0.000 description 2
- 206010018338 Glioma Diseases 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 102000004989 Hepsin Human genes 0.000 description 2
- 108090001101 Hepsin Proteins 0.000 description 2
- 241000713887 Human endogenous retrovirus Species 0.000 description 2
- 102100004115 ICAM1 Human genes 0.000 description 2
- 229940072221 IMMUNOGLOBULINS Drugs 0.000 description 2
- 102100019333 ITGA1 Human genes 0.000 description 2
- 101710006705 ITGA1 Proteins 0.000 description 2
- 101710006669 ITGA6 Proteins 0.000 description 2
- 102100012153 ITGAD Human genes 0.000 description 2
- 101710006584 ITGAD Proteins 0.000 description 2
- 102100012151 ITGAE Human genes 0.000 description 2
- 101710006585 ITGAE Proteins 0.000 description 2
- 102100019441 ITGAM Human genes 0.000 description 2
- 102100019437 ITGAX Human genes 0.000 description 2
- 101710006689 ITGAX Proteins 0.000 description 2
- 102100001478 ITGB1 Human genes 0.000 description 2
- 101710006661 ITGB1 Proteins 0.000 description 2
- 229960001101 Ifosfamide Drugs 0.000 description 2
- HOMGKSMUEGBAAB-UHFFFAOYSA-N Ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 2
- KTUFNOKKBVMGRW-UHFFFAOYSA-N Imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 2
- DOUYETYNHWVLEO-UHFFFAOYSA-N Imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 2
- 102000004851 Immunoglobulin G Human genes 0.000 description 2
- 108090001095 Immunoglobulin G Proteins 0.000 description 2
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 2
- 102000008070 Interferon-gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 108090001007 Interleukin-8 Proteins 0.000 description 2
- UWKQSNNFCGGAFS-XIFFEERXSA-N Irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 2
- 108050009808 Isoaspartyl-dipeptidase Proteins 0.000 description 2
- 101700086173 KLRF1 Proteins 0.000 description 2
- 102100019598 KLRF1 Human genes 0.000 description 2
- 210000003734 Kidney Anatomy 0.000 description 2
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-2-aminohexanoic acid zwitterion Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 2
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine zwitterion Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- 239000005517 L01XE01 - Imatinib Substances 0.000 description 2
- 102200131020 LINS1 M67A Human genes 0.000 description 2
- 208000009721 Leukemia, Monocytic, Acute Diseases 0.000 description 2
- 210000002751 Lymph Anatomy 0.000 description 2
- 210000003712 Lysosomes Anatomy 0.000 description 2
- 102100012667 MIPEP Human genes 0.000 description 2
- 101700005917 MMP10 Proteins 0.000 description 2
- 102100016820 MMP10 Human genes 0.000 description 2
- 102100018201 MMP17 Human genes 0.000 description 2
- 101700031813 MMP17 Proteins 0.000 description 2
- 102100012746 MMP20 Human genes 0.000 description 2
- 101700010802 MMP20 Proteins 0.000 description 2
- 101710032498 MMP23B Proteins 0.000 description 2
- 101700048088 MMP26 Proteins 0.000 description 2
- 102100012739 MMP26 Human genes 0.000 description 2
- 101700057314 MMP7 Proteins 0.000 description 2
- 102100014892 MMP7 Human genes 0.000 description 2
- 101700042140 MMP8 Proteins 0.000 description 2
- 102100014897 MMP8 Human genes 0.000 description 2
- 102100000575 MST1 Human genes 0.000 description 2
- 102100006037 MUC1 Human genes 0.000 description 2
- 101700052761 MUC1 Proteins 0.000 description 2
- 108091009047 Macrophage stimulating protein Proteins 0.000 description 2
- 206010025650 Malignant melanoma Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000007054 Medullary Carcinoma Diseases 0.000 description 2
- 102000013800 Meprin beta subunit Human genes 0.000 description 2
- 108050003615 Meprin beta subunit Proteins 0.000 description 2
- 241000579835 Merops Species 0.000 description 2
- 108020004999 Messenger RNA Proteins 0.000 description 2
- 108090000591 Metallocarboxypeptidase D Proteins 0.000 description 2
- 206010061289 Metastatic neoplasm Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229960004857 Mitomycin Drugs 0.000 description 2
- 210000001616 Monocytes Anatomy 0.000 description 2
- 101710005852 Msm_0361 Proteins 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 2
- BRMWTNUJHUMWMS-LURJTMIESA-N N(tele)-methyl-L-histidine Chemical compound CN1C=NC(C[C@H](N)C(O)=O)=C1 BRMWTNUJHUMWMS-LURJTMIESA-N 0.000 description 2
- 102000008822 Neuroligin 4 Human genes 0.000 description 2
- 108050000725 Neuroligin 4 Proteins 0.000 description 2
- 102100003153 OMA1 Human genes 0.000 description 2
- 101700054584 OMA1 Proteins 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 229960003104 Ornithine Drugs 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010025310 Other lymphomas Diseases 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 210000001672 Ovary Anatomy 0.000 description 2
- 102100001905 PFAS Human genes 0.000 description 2
- 101710034855 PFAS Proteins 0.000 description 2
- 102100013251 PKD1 Human genes 0.000 description 2
- 101710027263 PKD1L2 Proteins 0.000 description 2
- 102100004367 PKD1L2 Human genes 0.000 description 2
- 101710010583 PLAU Proteins 0.000 description 2
- 102100019806 PREP Human genes 0.000 description 2
- 102100005189 PRSS3 Human genes 0.000 description 2
- 101710042152 PRSS3 Proteins 0.000 description 2
- 102100006605 PRSS53 Human genes 0.000 description 2
- 101710043673 PRSS53 Proteins 0.000 description 2
- 101710033516 PSMA7 Proteins 0.000 description 2
- 102100011593 PSMA7 Human genes 0.000 description 2
- 208000008443 Pancreatic Carcinoma Diseases 0.000 description 2
- 108090000155 Pancreatic elastase II Proteins 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- BZQFBWGGLXLEPQ-REOHCLBHSA-N Phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 229940012957 Plasmin Drugs 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 102000014961 Protein Precursors Human genes 0.000 description 2
- 108010078762 Protein Precursors Proteins 0.000 description 2
- PBMFSQRYOILNGV-UHFFFAOYSA-N Pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 2
- 102000014128 RANK Ligand Human genes 0.000 description 2
- 108010025832 RANK Ligand Proteins 0.000 description 2
- 102100000775 REN Human genes 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000006265 Renal Cell Carcinoma Diseases 0.000 description 2
- 108090000783 Renin Proteins 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 102000020234 S-formylglutathione hydrolase Human genes 0.000 description 2
- 108010093322 S-formylglutathione hydrolase Proteins 0.000 description 2
- 102100001289 SEMA4D Human genes 0.000 description 2
- 101710023772 SEMA4D Proteins 0.000 description 2
- 101710028439 SLAMF1 Proteins 0.000 description 2
- 101700015221 ST14 Proteins 0.000 description 2
- 229940095743 Selective estrogen receptor modulators Drugs 0.000 description 2
- 108010074687 Signaling Lymphocytic Activation Molecule Family Member 1 Proteins 0.000 description 2
- 108010055297 Sterol Esterase Proteins 0.000 description 2
- 102000000019 Sterol Esterase Human genes 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N Sulfanilamide Chemical group NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 102100003033 TMPRSS11E Human genes 0.000 description 2
- 101710009828 TMPRSS11E Proteins 0.000 description 2
- 102100001067 TMPRSS4 Human genes 0.000 description 2
- 101710044691 TMPRSS4 Proteins 0.000 description 2
- 102100016217 TPP1 Human genes 0.000 description 2
- 102100011933 TPP2 Human genes 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 229960001603 Tamoxifen Drugs 0.000 description 2
- 229960001196 Thiotepa Drugs 0.000 description 2
- UCFGDBYHRUNTLO-QHCPKHFHSA-N Topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 description 2
- 102100015870 USP35 Human genes 0.000 description 2
- 101710010118 USP35 Proteins 0.000 description 2
- 102100011579 USP7 Human genes 0.000 description 2
- 108010032448 Ubiquitin-Specific Peptidase 7 Proteins 0.000 description 2
- 210000003462 Veins Anatomy 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010049644 Williams syndrome Diseases 0.000 description 2
- 201000001305 Williams-Beuren syndrome Diseases 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 101710038776 acyI Proteins 0.000 description 2
- 125000002015 acyclic group Chemical group 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 230000001195 anabolic Effects 0.000 description 2
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial Effects 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 108010087173 bile salt-stimulated lipase Proteins 0.000 description 2
- 102000024070 binding proteins Human genes 0.000 description 2
- 108091007650 binding proteins Proteins 0.000 description 2
- 201000000053 blastoma Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 230000001925 catabolic Effects 0.000 description 2
- 230000024881 catalytic activity Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 description 2
- 150000001945 cysteines Chemical class 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229960004242 dronabinol Drugs 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 201000008184 embryoma Diseases 0.000 description 2
- 230000003511 endothelial Effects 0.000 description 2
- 239000000328 estrogen antagonist Substances 0.000 description 2
- 108010038795 estrogen receptors Proteins 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 108010062699 gamma-Glutamyl Hydrolase Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic Effects 0.000 description 2
- 229960002411 imatinib Drugs 0.000 description 2
- 230000002519 immonomodulatory Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 201000006334 interstitial nephritis Diseases 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 101700053727 lipY Proteins 0.000 description 2
- 238000011068 load Methods 0.000 description 2
- 230000002934 lysing Effects 0.000 description 2
- 230000001868 lysosomic Effects 0.000 description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 230000001404 mediated Effects 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 2
- 229960001428 mercaptopurine Drugs 0.000 description 2
- 229920002106 messenger RNA Polymers 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 108010090530 metallocarboxypeptidase Z Proteins 0.000 description 2
- 230000001394 metastastic Effects 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- GIYXAJPCNFJEHY-UHFFFAOYSA-N methyl-[3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]azanium;chloride Chemical compound Cl.C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 GIYXAJPCNFJEHY-UHFFFAOYSA-N 0.000 description 2
- 108010047660 mitochondrial intermediate peptidase Proteins 0.000 description 2
- 230000000051 modifying Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 102000004990 neuroligin 1 Human genes 0.000 description 2
- 108090001100 neuroligin 1 Proteins 0.000 description 2
- 108090001075 neuroligin 2 Proteins 0.000 description 2
- 102000004872 neuroligin 2 Human genes 0.000 description 2
- 108090001073 neuroligin 3 Proteins 0.000 description 2
- 102000004871 neuroligin 3 Human genes 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 229960001756 oxaliplatin Drugs 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- 125000000160 oxazolidinyl group Chemical group 0.000 description 2
- LFGREXWGYUGZLY-UHFFFAOYSA-N oxophosphanyl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 2
- 201000002528 pancreatic cancer Diseases 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 230000002093 peripheral Effects 0.000 description 2
- 230000000896 plasminic Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 108010059054 polycystic kidney disease 1 protein Proteins 0.000 description 2
- 230000000750 progressive Effects 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- 239000000333 selective estrogen receptor modulator Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 230000004936 stimulating Effects 0.000 description 2
- 229960001663 sulfanilamide Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 102000005488 thioesterase family Human genes 0.000 description 2
- 108020002982 thioesterase family Proteins 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 2
- 229960000303 topotecan Drugs 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 230000001131 transforming Effects 0.000 description 2
- 108010039203 tripeptidyl-peptidase 1 Proteins 0.000 description 2
- 108010039189 tripeptidyl-peptidase 2 Proteins 0.000 description 2
- 201000005112 urinary bladder cancer Diseases 0.000 description 2
- COFJBSXICYYSKG-FJFFLIEUSA-N vindesine sulfate Chemical compound OS(O)(=O)=O.C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(N)=O)N4C)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 COFJBSXICYYSKG-FJFFLIEUSA-N 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- SYOKIDBDQMKNDQ-HHUWHTLVSA-N (2S)-1-[2-[[(5S,7R)-3-hydroxy-1-adamantyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C([C@@H]1C[C@H](C2)CC(C1)(C1)O)C21NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-HHUWHTLVSA-N 0.000 description 1
- VGGGPCQERPFHOB-RDBSUJKOSA-N (2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-RDBSUJKOSA-N 0.000 description 1
- YXTKHLHCVFUPPT-YYFJYKOTSA-N (2S)-2-[[4-[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;(1R,2R)-1,2-dimethanidylcyclohexane;5-fluoro-1H-pyrimidine-2,4-dione;oxalic acid;platinum(2+) Chemical compound [Pt+2].OC(=O)C(O)=O.[CH2-][C@@H]1CCCC[C@H]1[CH2-].FC1=CNC(=O)NC1=O.C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 YXTKHLHCVFUPPT-YYFJYKOTSA-N 0.000 description 1
- FSIRXIHZBIXHKT-MHTVFEQDSA-N (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)butan-2-yl]benzoyl]amino]pentanedioic acid Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CC(CC)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FSIRXIHZBIXHKT-MHTVFEQDSA-N 0.000 description 1
- LDLGBNXSBZFATB-BYPYZUCNSA-N (2S)-5-amino-2-(difluoromethylamino)pentanoic acid Chemical compound NCCC[C@@H](C(O)=O)NC(F)F LDLGBNXSBZFATB-BYPYZUCNSA-N 0.000 description 1
- NRUKOCRGYNPUPR-QBPJDGROSA-N (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 1
- CYQFCXCEBYINGO-ZYMOGRSISA-N (6aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-ZYMOGRSISA-N 0.000 description 1
- VWUXBMIQPBEWFH-WCCTWKNTSA-N (7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC2=C1 VWUXBMIQPBEWFH-WCCTWKNTSA-N 0.000 description 1
- JXVAMODRWBNUSF-KZQKBALLSA-N (7S,9R,10R)-7-[(2R,4S,5S,6S)-5-[[(2S,4aS,5aS,7S,9S,9aR,10aR)-2,9-dimethyl-3-oxo-4,4a,5a,6,7,9,9a,10a-octahydrodipyrano[4,2-a:4',3'-e][1,4]dioxin-7-yl]oxy]-4-(dimethylamino)-6-methyloxan-2-yl]oxy-10-[(2S,4S,5S,6S)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2 Chemical compound O([C@@H]1C2=C(O)C=3C(=O)C4=CC=CC(O)=C4C(=O)C=3C(O)=C2[C@@H](O[C@@H]2O[C@@H](C)[C@@H](O[C@@H]3O[C@@H](C)[C@H]4O[C@@H]5O[C@@H](C)C(=O)C[C@@H]5O[C@H]4C3)[C@H](C2)N(C)C)C[C@]1(O)CC)[C@H]1C[C@H](N(C)C)[C@H](O)[C@H](C)O1 JXVAMODRWBNUSF-KZQKBALLSA-N 0.000 description 1
- MWWSFMDVAYGXBV-FGBJBKNOSA-N (7S,9S)-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)C1CC(N)C(O)C(C)O1 MWWSFMDVAYGXBV-FGBJBKNOSA-N 0.000 description 1
- NOPNWHSMQOXAEI-PUCKCBAPSA-N (7S,9S)-7-[(2R,4S,5S,6S)-4-(2,3-dihydropyrrol-1-yl)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione Chemical compound N1([C@H]2C[C@@H](O[C@@H](C)[C@H]2O)O[C@H]2C[C@@](O)(CC=3C(O)=C4C(=O)C=5C=CC=C(C=5C(=O)C4=C(O)C=32)OC)C(=O)CO)CCC=C1 NOPNWHSMQOXAEI-PUCKCBAPSA-N 0.000 description 1
- KMSKQZKKOZQFFG-YXRRJAAWSA-N (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione Chemical compound O([C@H]1[C@@H](N)C[C@@H](O[C@H]1C)O[C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@@H]1CCCCO1 KMSKQZKKOZQFFG-YXRRJAAWSA-N 0.000 description 1
- IEXUMDBQLIVNHZ-YOUGDJEHSA-N (8S,11R,13R,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(O)CCCO)[C@@]2(C)C1 IEXUMDBQLIVNHZ-YOUGDJEHSA-N 0.000 description 1
- 125000006584 (C3-C10) heterocycloalkyl group Chemical group 0.000 description 1
- AGNGYMCLFWQVGX-AGFFZDDWSA-N (E)-1-[(2S)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 description 1
- FONKWHRXTPJODV-DNQXCXABSA-N 1,3-bis[2-[(8S)-8-(chloromethyl)-4-hydroxy-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indole-6-carbonyl]-1H-indol-5-yl]urea Chemical compound C1([C@H](CCl)CN2C(=O)C=3NC4=CC=C(C=C4C=3)NC(=O)NC=3C=C4C=C(NC4=CC=3)C(=O)N3C4=CC(O)=C5NC=C(C5=C4[C@H](CCl)C3)C)=C2C=C(O)C2=C1C(C)=CN2 FONKWHRXTPJODV-DNQXCXABSA-N 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N 1,4-Butanediol, dimethanesulfonate Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- BTOTXLJHDSNXMW-POYBYMJQSA-N 1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O1[C@H](CO)CC[C@@H]1N1C(=O)NC(=O)C=C1 BTOTXLJHDSNXMW-POYBYMJQSA-N 0.000 description 1
- FHJATBIERQTCTN-UHFFFAOYSA-N 1-[4-amino-2-(ethylaminomethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol Chemical compound C1=CC=CC2=C(N(C(CNCC)=N3)CC(C)(C)O)C3=C(N)N=C21 FHJATBIERQTCTN-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N 2-Pyrrolidone Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- QCXJFISCRQIYID-IAEPZHFASA-N 2-amino-1-N-[(3S,6S,7R,10S,16S)-3-[(2S)-butan-2-yl]-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-10-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-9-N-[(3S,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propa Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N=C2C(C(=O)N[C@@H]3C(=O)N[C@H](C(N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]3C)=O)[C@@H](C)CC)=C(N)C(=O)C(C)=C2O2)C2=C(C)C=C1 QCXJFISCRQIYID-IAEPZHFASA-N 0.000 description 1
- DBIGHPPNXATHOF-UHFFFAOYSA-N 3-(3-methylsulfonyloxypropylamino)propyl methanesulfonate Chemical compound CS(=O)(=O)OCCCNCCCOS(C)(=O)=O DBIGHPPNXATHOF-UHFFFAOYSA-N 0.000 description 1
- PWMYMKOUNYTVQN-UHFFFAOYSA-N 3-(8,8-diethyl-2-aza-8-germaspiro[4.5]decan-2-yl)-N,N-dimethylpropan-1-amine Chemical compound C1C[Ge](CC)(CC)CCC11CN(CCCN(C)C)CC1 PWMYMKOUNYTVQN-UHFFFAOYSA-N 0.000 description 1
- 101710027271 3b Proteins 0.000 description 1
- YIMDLWDNDGKDTJ-ABYLTEMBSA-N 4-[(2S,3S,4S)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]morpholine-3-carbonitrile Chemical compound N1([C@H]2CC(O[C@@H](C)[C@H]2O)O[C@H]2C[C@@](O)(CC=3C(O)=C4C(=O)C=5C=CC=C(C=5C(=O)C4=C(O)C=32)OC)C(=O)CO)CCOCC1C#N YIMDLWDNDGKDTJ-ABYLTEMBSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- DHMYGZIEILLVNR-UHFFFAOYSA-N 5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione;1H-pyrimidine-2,4-dione Chemical compound O=C1C=CNC(=O)N1.O=C1NC(=O)C(F)=CN1C1OCCC1 DHMYGZIEILLVNR-UHFFFAOYSA-N 0.000 description 1
- WYXSYVWAUAUWLD-SHUUEZRQSA-N 6-azauridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=N1 WYXSYVWAUAUWLD-SHUUEZRQSA-N 0.000 description 1
- FUXVKZWTXQUGMW-FQEVSTJZSA-N 9-Aminocamptothecin Chemical compound C1=CC(N)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 FUXVKZWTXQUGMW-FQEVSTJZSA-N 0.000 description 1
- 102100017803 ABHD16B Human genes 0.000 description 1
- 101710011450 ABHD16B Proteins 0.000 description 1
- 102100011385 ABHD4 Human genes 0.000 description 1
- 101700010684 ABHD4 Proteins 0.000 description 1
- 108060006693 ABL Proteins 0.000 description 1
- 102100017866 ACE2 Human genes 0.000 description 1
- 101710014780 ADAM1 Proteins 0.000 description 1
- 102100010291 ADAM11 Human genes 0.000 description 1
- 101710043079 ADAM11 Proteins 0.000 description 1
- 102100010287 ADAM15 Human genes 0.000 description 1
- 101710043073 ADAM18 Proteins 0.000 description 1
- 102100010283 ADAM18 Human genes 0.000 description 1
- 101710043083 ADAM19 Proteins 0.000 description 1
- 101700072668 ADAM2 Proteins 0.000 description 1
- 102100017435 ADAM2 Human genes 0.000 description 1
- 102100001915 ADAM22 Human genes 0.000 description 1
- 101710043117 ADAM22 Proteins 0.000 description 1
- 102100002254 ADAM32 Human genes 0.000 description 1
- 101710042946 ADAM32 Proteins 0.000 description 1
- 101700064649 ADAM7 Proteins 0.000 description 1
- 102100012525 ADAM7 Human genes 0.000 description 1
- 102100012519 ADAM8 Human genes 0.000 description 1
- 101710026630 ADAM8 Proteins 0.000 description 1
- 102100012515 ADAM9 Human genes 0.000 description 1
- 101700048048 ADAM9 Proteins 0.000 description 1
- 102100003881 ADAMDEC1 Human genes 0.000 description 1
- 101710045132 ADAMDEC1 Proteins 0.000 description 1
- 108091005652 ADAMTS1 Proteins 0.000 description 1
- 108091005660 ADAMTS10 Proteins 0.000 description 1
- 108091005663 ADAMTS12 Proteins 0.000 description 1
- 108091005662 ADAMTS13 Proteins 0.000 description 1
- 108091005665 ADAMTS14 Proteins 0.000 description 1
- 108091005664 ADAMTS15 Proteins 0.000 description 1
- 108091005667 ADAMTS16 Proteins 0.000 description 1
- 108091005666 ADAMTS17 Proteins 0.000 description 1
- 108091005655 ADAMTS5 Proteins 0.000 description 1
- 108091005657 ADAMTS6 Proteins 0.000 description 1
- 108091005661 ADAMTS9 Proteins 0.000 description 1
- 102100010892 ADGRG4 Human genes 0.000 description 1
- 101710005053 ADGRG4 Proteins 0.000 description 1
- 101710038364 AFG3L2 Proteins 0.000 description 1
- 102100017291 AFG3L2 Human genes 0.000 description 1
- 102100020405 AGA Human genes 0.000 description 1
- 102100001661 ALG13 Human genes 0.000 description 1
- 101700070408 ALG13 Proteins 0.000 description 1
- 229940100198 ALKYLATING AGENTS Drugs 0.000 description 1
- 102100018031 AMZ1 Human genes 0.000 description 1
- 101700008389 AMZ1 Proteins 0.000 description 1
- 102100018030 AMZ2 Human genes 0.000 description 1
- 101700012726 AMZ2 Proteins 0.000 description 1
- 102100004845 ARHGEF5 Human genes 0.000 description 1
- 101700076374 ASNS Proteins 0.000 description 1
- 229960003272 ASPARAGINASE Drugs 0.000 description 1
- 102100017828 ASPRV1 Human genes 0.000 description 1
- 101710024273 ASPRV1 Proteins 0.000 description 1
- 101710039338 ATP2A2 Proteins 0.000 description 1
- 102100005631 ATP2A2 Human genes 0.000 description 1
- 102100017901 ATXN3 Human genes 0.000 description 1
- 102200043458 ATXN3 C14A Human genes 0.000 description 1
- 102100009681 ATXN3L Human genes 0.000 description 1
- 101710005313 ATXN3L Proteins 0.000 description 1
- 229940028652 Abraxane Drugs 0.000 description 1
- 102000006772 Acid Ceramidase Human genes 0.000 description 1
- 108020005296 Acid Ceramidase Proteins 0.000 description 1
- 208000004064 Acoustic Neuroma Diseases 0.000 description 1
- 229940037127 Actonel Drugs 0.000 description 1
- 210000004100 Adrenal Glands Anatomy 0.000 description 1
- 229940009456 Adriamycin Drugs 0.000 description 1
- TXUZVZSFRXZGTL-QPLCGJKRSA-N Afimoxifene Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=C(O)C=C1 TXUZVZSFRXZGTL-QPLCGJKRSA-N 0.000 description 1
- 229940062527 Alendronate Drugs 0.000 description 1
- 229940045714 Alkyl sulfonate alkylating agents Drugs 0.000 description 1
- ZSBOMTDTBDDKMP-OAHLLOKOSA-N Alogliptin Chemical compound C=1C=CC=C(C#N)C=1CN1C(=O)N(C)C(=O)C=C1N1CCC[C@@H](N)C1 ZSBOMTDTBDDKMP-OAHLLOKOSA-N 0.000 description 1
- UUVWYPNAQBNQJQ-UHFFFAOYSA-N Altretamine Chemical compound CN(C)C1=NC(N(C)C)=NC(N(C)C)=N1 UUVWYPNAQBNQJQ-UHFFFAOYSA-N 0.000 description 1
- 229960003896 Aminopterin Drugs 0.000 description 1
- 229960001220 Amsacrine Drugs 0.000 description 1
- XCPGHVQEEXUHNC-UHFFFAOYSA-N Amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 description 1
- 240000002254 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- YBBLVLTVTVSKRW-UHFFFAOYSA-N Anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 description 1
- 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 description 1
- 108010083359 Antigen Receptors Proteins 0.000 description 1
- 102000006306 Antigen Receptors Human genes 0.000 description 1
- 108010047814 Antigen-Antibody Complex Proteins 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 description 1
- 229940087620 Aromasin Drugs 0.000 description 1
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 description 1
- 108010078554 Aromatase Proteins 0.000 description 1
- 229940046844 Aromatase inhibitors Drugs 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- 102000015790 Asparaginase Human genes 0.000 description 1
- 229940009098 Aspartate Drugs 0.000 description 1
- 108010023546 Aspartylglucosylaminase Proteins 0.000 description 1
- 108010032947 Ataxin-3 Proteins 0.000 description 1
- 229950002916 Avelumab Drugs 0.000 description 1
- 229960002756 Azacitidine Drugs 0.000 description 1
- 108091008154 B cell receptors Proteins 0.000 description 1
- 101700044176 BACE Proteins 0.000 description 1
- 101700051112 BACE1 Proteins 0.000 description 1
- 102100015648 BACE2 Human genes 0.000 description 1
- 229950006844 BIZELESIN Drugs 0.000 description 1
- 102100007313 BMP1 Human genes 0.000 description 1
- 101700046223 BMP1 Proteins 0.000 description 1
- 101700031214 BRCC3 Proteins 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 230000037177 Biodistribution Effects 0.000 description 1
- 229940112871 Bisphosphonate drugs affecting bone structure and mineralization Drugs 0.000 description 1
- 229960001561 Bleomycin Drugs 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 210000001124 Body Fluids Anatomy 0.000 description 1
- 210000000481 Breast Anatomy 0.000 description 1
- 206010006417 Bronchial carcinoma Diseases 0.000 description 1
- 208000003362 Bronchogenic Carcinoma Diseases 0.000 description 1
- 229960005064 Buserelin Acetate Drugs 0.000 description 1
- PYMDEDHDQYLBRT-DRIHCAFSSA-N Buserelin acetate Chemical compound CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 PYMDEDHDQYLBRT-DRIHCAFSSA-N 0.000 description 1
- XREUEWVEMYWFFA-CSKJXFQVSA-N CARUBICIN Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=C(O)C=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XREUEWVEMYWFFA-CSKJXFQVSA-N 0.000 description 1
- 229950001725 CARUBICIN Drugs 0.000 description 1
- 102100006374 CASP1 Human genes 0.000 description 1
- 108010017009 CD11b Antigen Proteins 0.000 description 1
- 102100005826 CD19 Human genes 0.000 description 1
- 101700087100 CD19 Proteins 0.000 description 1
- 102100000188 CD244 Human genes 0.000 description 1
- 101700000388 CD244 Proteins 0.000 description 1
- 102100013077 CD4 Human genes 0.000 description 1
- 101700022938 CD4 Proteins 0.000 description 1
- 101700080416 CD69 Proteins 0.000 description 1
- 102100005832 CD69 Human genes 0.000 description 1
- 102100008204 CD82 Human genes 0.000 description 1
- 101700087069 CD82 Proteins 0.000 description 1
- 102100008186 CD83 Human genes 0.000 description 1
- 101700013105 CD83 Proteins 0.000 description 1
- 102100017642 CD84 Human genes 0.000 description 1
- 101710028436 CD84 Proteins 0.000 description 1
- 102100011828 CEACAM1 Human genes 0.000 description 1
- 101710043957 CEACAM1 Proteins 0.000 description 1
- 102100006088 CELA2B Human genes 0.000 description 1
- 101710017129 CELA2B Proteins 0.000 description 1
- 101710034295 CES1P1 Proteins 0.000 description 1
- 102100019338 CES1P1 Human genes 0.000 description 1
- 102100001457 CES2 Human genes 0.000 description 1
- 101700045507 CES2 Proteins 0.000 description 1
- 102100016295 CFI Human genes 0.000 description 1
- 102100013000 CFLAR Human genes 0.000 description 1
- 101700079603 CFLAR Proteins 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-L CHEBI:8154 Chemical class [O-]P([O-])=O ABLZXFCXXLZCGV-UHFFFAOYSA-L 0.000 description 1
- FDKXTQMXEQVLRF-ZHACJKMWSA-N CN(C)\N=N\c1[nH]cnc1C(N)=O Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 description 1
- 102100007493 CNTF Human genes 0.000 description 1
- 101710035136 COPS5 Proteins 0.000 description 1
- 102100001962 COPS8 Human genes 0.000 description 1
- 101710035133 COPS8 Proteins 0.000 description 1
- 102100003769 CPA1 Human genes 0.000 description 1
- 101710003550 CPA1 Proteins 0.000 description 1
- 102100003771 CPA2 Human genes 0.000 description 1
- 101710003552 CPA3 Proteins 0.000 description 1
- 102100003121 CPA5 Human genes 0.000 description 1
- 101710003555 CPA5 Proteins 0.000 description 1
- 102100003122 CPA6 Human genes 0.000 description 1
- 101710003559 CPA6 Proteins 0.000 description 1
- 102100006002 CPB1 Human genes 0.000 description 1
- 102100005992 CPB2 Human genes 0.000 description 1
- 101710023621 CPC735_009100 Proteins 0.000 description 1
- 102100019263 CPD Human genes 0.000 description 1
- 102100019264 CPE Human genes 0.000 description 1
- 102100019426 CPM Human genes 0.000 description 1
- 102100015814 CPXM1 Human genes 0.000 description 1
- 101700020394 CPXM1 Proteins 0.000 description 1
- 102100011418 CRTAM Human genes 0.000 description 1
- 102100006435 CSF3 Human genes 0.000 description 1
- 102100015378 CTSL Human genes 0.000 description 1
- 102100015379 CTSS Human genes 0.000 description 1
- 101710010384 CTSV Proteins 0.000 description 1
- 101700069118 CXE2 Proteins 0.000 description 1
- 101710005746 CYS-PIN Proteins 0.000 description 1
- 101700008313 CYTI Proteins 0.000 description 1
- 229950009908 Cactinomycin Drugs 0.000 description 1
- 102000000905 Cadherins Human genes 0.000 description 1
- 108050007957 Cadherins Proteins 0.000 description 1
- 229940088954 Camptosar Drugs 0.000 description 1
- FSBIGDSBMBYOPN-VKHMYHEASA-N Canavanine Chemical compound OC(=O)[C@@H](N)CCONC(N)=N FSBIGDSBMBYOPN-VKHMYHEASA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 229960004117 Capecitabine Drugs 0.000 description 1
- OLESAACUTLOWQZ-UHFFFAOYSA-L Carboplatin Chemical compound O=C1O[Pt]([N]([H])([H])[H])([N]([H])([H])[H])OC(=O)C11CCC1 OLESAACUTLOWQZ-UHFFFAOYSA-L 0.000 description 1
- 229960004562 Carboplatin Drugs 0.000 description 1
- 108090000087 Carboxypeptidase B Proteins 0.000 description 1
- 108090000201 Carboxypeptidase B2 Proteins 0.000 description 1
- 108010058255 Carboxypeptidase H Proteins 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 210000000845 Cartilage Anatomy 0.000 description 1
- 108090000426 Caspase 1 Proteins 0.000 description 1
- 102000004066 Caspase-12 Human genes 0.000 description 1
- 108090000570 Caspase-12 Proteins 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- 108090000258 Cathepsin D Proteins 0.000 description 1
- 102000003908 Cathepsin D Human genes 0.000 description 1
- 108090000611 Cathepsin E Proteins 0.000 description 1
- 102000004178 Cathepsin E Human genes 0.000 description 1
- 102000004173 Cathepsin G Human genes 0.000 description 1
- 108090000617 Cathepsin G Proteins 0.000 description 1
- 108090000625 Cathepsin K Proteins 0.000 description 1
- 108090000624 Cathepsin L Proteins 0.000 description 1
- 108090000613 Cathepsin S Proteins 0.000 description 1
- 102000011937 Cathepsin Z Human genes 0.000 description 1
- 108010061117 Cathepsin Z Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- CZTQZXZIADLWOZ-CRAIPNDOSA-N Cephaloridine Chemical compound O=C([C@@H](NC(=O)CC=1SC=CC=1)[C@H]1SC2)N1C(C(=O)[O-])=C2C[N+]1=CC=CC=C1 CZTQZXZIADLWOZ-CRAIPNDOSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 101710032139 Ces2c Proteins 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 229960004630 Chlorambucil Drugs 0.000 description 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N Chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
- BFPSDSIWYFKGBC-UHFFFAOYSA-N Chlorotrianisene Chemical compound C1=CC(OC)=CC=C1C(Cl)=C(C=1C=CC(OC)=CC=1)C1=CC=C(OC)C=C1 BFPSDSIWYFKGBC-UHFFFAOYSA-N 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 206010008943 Chronic leukaemia Diseases 0.000 description 1
- 206010008958 Chronic lymphocytic leukaemia Diseases 0.000 description 1
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N Cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 230000036849 Clc Effects 0.000 description 1
- 229960002286 Clodronic Acid Drugs 0.000 description 1
- 108090000056 Complement Factor B Proteins 0.000 description 1
- 102000003712 Complement Factor B Human genes 0.000 description 1
- 102000003706 Complement Factor D Human genes 0.000 description 1
- 108090000059 Complement Factor D Proteins 0.000 description 1
- 108090000044 Complement Factor I Proteins 0.000 description 1
- 229920000453 Consensus sequence Polymers 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 229960004397 Cyclophosphamide Drugs 0.000 description 1
- 210000000805 Cytoplasm Anatomy 0.000 description 1
- 229940104302 Cytosine Drugs 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N Cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- 102100013390 DAG1 Human genes 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N DAUNOMYCIN Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- QGJUIPDUBHWZPV-YQBUGCKMSA-N DB07465 Chemical compound C([C@@H](C1)C2)[C@@H](C3)C[C@@]1(O)C[C@]23[C@H](N)C(=O)N1[C@H](C#N)C[C@@H]2C[C@@H]21 QGJUIPDUBHWZPV-YQBUGCKMSA-N 0.000 description 1
- 102100019946 DHH Human genes 0.000 description 1
- 101700012961 DHH Proteins 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N DL-aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 102100014977 DPP7 Human genes 0.000 description 1
- 102100005620 DPYS Human genes 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- BMKDZUISNHGIBY-ZETCQYMHSA-N Dexrazoxane Chemical compound C([C@H](C)N1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 BMKDZUISNHGIBY-ZETCQYMHSA-N 0.000 description 1
- AUGQEEXBDZWUJY-NMAPUUFXSA-N Diacetoxyscirpenol Chemical compound C([C@@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@@H]1C=C(C)CC[C@@]13COC(=O)C)O2 AUGQEEXBDZWUJY-NMAPUUFXSA-N 0.000 description 1
- 102000012122 Dihydropyrimidinase-related protein 1 Human genes 0.000 description 1
- 108050002656 Dihydropyrimidinase-related protein 1 Proteins 0.000 description 1
- 102000011972 Dihydropyrimidinase-related protein 2 Human genes 0.000 description 1
- 102000012123 Dihydropyrimidinase-related protein 3 Human genes 0.000 description 1
- 108050002650 Dihydropyrimidinase-related protein 3 Proteins 0.000 description 1
- 102000011993 Dihydropyrimidinase-related protein 4 Human genes 0.000 description 1
- 108050002475 Dihydropyrimidinase-related protein 4 Proteins 0.000 description 1
- 102000012120 Dihydropyrimidinase-related protein 5 Human genes 0.000 description 1
- 108050002654 Dihydropyrimidinase-related protein 5 Proteins 0.000 description 1
- 108090000212 Dipeptidyl-peptidase II Proteins 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 230000036947 Dissociation constant Effects 0.000 description 1
- CYQFCXCEBYINGO-DLBZAZTESA-N Dronabinol Natural products C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@H]21 CYQFCXCEBYINGO-DLBZAZTESA-N 0.000 description 1
- VQNATVDKACXKTF-XELLLNAOSA-N Duocarmycin Chemical compound COC1=C(OC)C(OC)=C2NC(C(=O)N3C4=CC(=O)C5=C([C@@]64C[C@@H]6C3)C=C(N5)C(=O)OC)=CC2=C1 VQNATVDKACXKTF-XELLLNAOSA-N 0.000 description 1
- 229950009791 Durvalumab Drugs 0.000 description 1
- 108010071885 Dystroglycans Proteins 0.000 description 1
- 102000003642 EC 2.3.2.5 Human genes 0.000 description 1
- 108010081484 EC 2.3.2.5 Proteins 0.000 description 1
- 108010039224 EC 2.4.2.14 Proteins 0.000 description 1
- 108010004098 EC 3.4.11.1 Proteins 0.000 description 1
- 102000002704 EC 3.4.11.1 Human genes 0.000 description 1
- 108030003253 EC 3.4.17.15 Proteins 0.000 description 1
- 108030000059 EC 3.4.17.4 Proteins 0.000 description 1
- 108030001421 EC 3.4.18.1 Proteins 0.000 description 1
- 108030007132 EC 3.4.21.64 Proteins 0.000 description 1
- 108030007211 EC 3.4.21.78 Proteins 0.000 description 1
- 108010013369 EC 3.4.21.9 Proteins 0.000 description 1
- 108030001384 EC 3.4.22.43 Proteins 0.000 description 1
- 108030001044 EC 3.4.23.45 Proteins 0.000 description 1
- 108030001047 EC 3.4.23.46 Proteins 0.000 description 1
- 108010070255 EC 6.3.1.1 Proteins 0.000 description 1
- 101700033006 EGF Proteins 0.000 description 1
- 102100010813 EGF Human genes 0.000 description 1
- 229940121647 EGFR inhibitors Drugs 0.000 description 1
- 108060002510 ELA1 Proteins 0.000 description 1
- 101700030458 ERAP1 Proteins 0.000 description 1
- 102100016201 ERAP1 Human genes 0.000 description 1
- 101700029185 ERAP2 Proteins 0.000 description 1
- 102100016202 ERAP2 Human genes 0.000 description 1
- 101700025368 ERBB2 Proteins 0.000 description 1
- 102000027760 ERBB2 Human genes 0.000 description 1
- 101700068868 ERMP1 Proteins 0.000 description 1
- ITSGNOIFAJAQHJ-BMFNZSJVSA-N ESORUBICIN Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)C[C@H](C)O1 ITSGNOIFAJAQHJ-BMFNZSJVSA-N 0.000 description 1
- 102000015782 Electron Transport Complex III Human genes 0.000 description 1
- 108010024882 Electron Transport Complex III Proteins 0.000 description 1
- 229940053594 Eligard Drugs 0.000 description 1
- 229940120655 Eloxatin Drugs 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 210000002615 Epidermis Anatomy 0.000 description 1
- 108050002910 Epoxide hydrolase-like Proteins 0.000 description 1
- 102000012377 Epoxide hydrolase-like Human genes 0.000 description 1
- 210000003238 Esophagus Anatomy 0.000 description 1
- 229950002017 Esorubicin Drugs 0.000 description 1
- UMILHIMHKXVDGH-UHFFFAOYSA-N Etoglucid Chemical compound C1OC1COCCOCCOCCOCC1CO1 UMILHIMHKXVDGH-UHFFFAOYSA-N 0.000 description 1
- 229960005237 Etoglucid Drugs 0.000 description 1
- 229940085363 Evista Drugs 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- 108090001126 FURIN Proteins 0.000 description 1
- 108010048049 Factor IXa Proteins 0.000 description 1
- 108010071241 Factor XIIa Proteins 0.000 description 1
- 108010080805 Factor XIa Proteins 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 229940087861 Faslodex Drugs 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229940087476 Femara Drugs 0.000 description 1
- 229960000304 Folic Acid Drugs 0.000 description 1
- 229940001490 Fosamax Drugs 0.000 description 1
- 229960002258 Fulvestrant Drugs 0.000 description 1
- 102000004961 Furin Human genes 0.000 description 1
- 102100017670 GATD1 Human genes 0.000 description 1
- 101700054748 GATD1 Proteins 0.000 description 1
- 102100018777 GATD3A Human genes 0.000 description 1
- 101710031273 GATD3A Proteins 0.000 description 1
- 102100018345 GFPT1 Human genes 0.000 description 1
- 101700069341 GFPT1 Proteins 0.000 description 1
- 101710016577 GGTLC2 Proteins 0.000 description 1
- 102100018371 GGTLC2 Human genes 0.000 description 1
- 102100004383 GZMA Human genes 0.000 description 1
- 102100004385 GZMH Human genes 0.000 description 1
- 101710014271 GZMH Proteins 0.000 description 1
- 102100004389 GZMK Human genes 0.000 description 1
- 101710014269 GZMK Proteins 0.000 description 1
- 206010017758 Gastric cancer Diseases 0.000 description 1
- 229940020967 Gemzar Drugs 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 229940049906 Glutamate Drugs 0.000 description 1
- 108090000369 Glutamate Carboxypeptidase II Proteins 0.000 description 1
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000013811 Granzyme M Human genes 0.000 description 1
- 108050003624 Granzyme M Proteins 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 102000013587 Guanine Deaminase Human genes 0.000 description 1
- 108010012029 Guanine Deaminase Proteins 0.000 description 1
- 229940093912 Gynecological Sulfonamides Drugs 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 210000002216 Heart Anatomy 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 208000001258 Hemangiosarcoma Diseases 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 210000003494 Hepatocytes Anatomy 0.000 description 1
- 201000006743 Hodgkin's lymphoma Diseases 0.000 description 1
- 229940099552 Hyaluronan Drugs 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N Hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940088013 Hycamtin Drugs 0.000 description 1
- 101700056821 ICIC Proteins 0.000 description 1
- 101710006761 ICY Proteins 0.000 description 1
- 101700046422 IFNA Proteins 0.000 description 1
- 101700077226 IGBP1 Proteins 0.000 description 1
- 102100008764 IGBP1 Human genes 0.000 description 1
- 101710003110 IL17A Proteins 0.000 description 1
- 102100008982 IL17A Human genes 0.000 description 1
- 102100018758 IL3 Human genes 0.000 description 1
- 101710006572 ITGAM Proteins 0.000 description 1
- 102100012517 ITGB7 Human genes 0.000 description 1
- 101710006575 ITGB7 Proteins 0.000 description 1
- 229940015872 Ibandronate Drugs 0.000 description 1
- 229960000908 Idarubicin Drugs 0.000 description 1
- XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin hydrochloride Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 1
- 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
- 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 108010030465 Integrin alpha6beta1 Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- 108090000174 Interleukin-10 Proteins 0.000 description 1
- 102000003814 Interleukin-10 Human genes 0.000 description 1
- 108090000177 Interleukin-11 Proteins 0.000 description 1
- 102000003815 Interleukin-11 Human genes 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 229940117681 Interleukin-12 Drugs 0.000 description 1
- 102000013462 Interleukin-12 Human genes 0.000 description 1
- 108090000176 Interleukin-13 Proteins 0.000 description 1
- 108090000172 Interleukin-15 Proteins 0.000 description 1
- 102000004125 Interleukin-1alpha Human genes 0.000 description 1
- 108010082786 Interleukin-1alpha Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 102000004388 Interleukin-4 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108010002586 Interleukin-7 Proteins 0.000 description 1
- 108010002335 Interleukin-9 Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 108010089187 Ipilimumab Proteins 0.000 description 1
- GURKHSYORGJETM-WAQYZQTGSA-N Irinotecan hydrochloride Chemical compound Cl.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 GURKHSYORGJETM-WAQYZQTGSA-N 0.000 description 1
- UXGVMFHEKMGWMA-UHFFFAOYSA-N Isobenzofuran Chemical compound C1=CC=CC2=COC=C21 UXGVMFHEKMGWMA-UHFFFAOYSA-N 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-N Isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N Isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N Isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 102100004464 KLK10 Human genes 0.000 description 1
- 101700050384 KLK10 Proteins 0.000 description 1
- 102100004459 KLK11 Human genes 0.000 description 1
- 101700039247 KLK11 Proteins 0.000 description 1
- 102100004461 KLK13 Human genes 0.000 description 1
- 101700042153 KLK13 Proteins 0.000 description 1
- 102100004462 KLK14 Human genes 0.000 description 1
- 101700012318 KLK14 Proteins 0.000 description 1
- 102100011337 KLK4 Human genes 0.000 description 1
- 102100011309 KLK5 Human genes 0.000 description 1
- 101700077195 KLK5 Proteins 0.000 description 1
- 102100011310 KLK6 Human genes 0.000 description 1
- 101700058468 KLK6 Proteins 0.000 description 1
- 102100011312 KLK7 Human genes 0.000 description 1
- 101700079133 KLK7 Proteins 0.000 description 1
- 102100005645 KLK8 Human genes 0.000 description 1
- 101700020455 KLK8 Proteins 0.000 description 1
- 102100017339 KLRC1 Human genes 0.000 description 1
- 101710036388 KLRC1 Proteins 0.000 description 1
- 102100012225 KLRC2 Human genes 0.000 description 1
- 101710036391 KLRC2 Proteins 0.000 description 1
- 101710036390 KLRK1 Proteins 0.000 description 1
- 102100012223 KLRK1 Human genes 0.000 description 1
- 210000002510 Keratinocytes Anatomy 0.000 description 1
- 101700070878 LAP1 Proteins 0.000 description 1
- 101710015837 LGALS9 Proteins 0.000 description 1
- 101710040442 LTBR Proteins 0.000 description 1
- 102100013136 LTBR Human genes 0.000 description 1
- 101710028176 LVRN Proteins 0.000 description 1
- 102100008092 LVRN Human genes 0.000 description 1
- 101700031346 LY9 Proteins 0.000 description 1
- 229940078795 Lactoferrin Drugs 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- BCFGMOOMADDAQU-UHFFFAOYSA-N Lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 206010024305 Leukaemia monocytic Diseases 0.000 description 1
- 208000000429 Leukemia, Lymphocytic, Chronic, B-Cell Diseases 0.000 description 1
- 208000008456 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Diseases 0.000 description 1
- 210000000265 Leukocytes Anatomy 0.000 description 1
- 229960004338 Leuprorelin Drugs 0.000 description 1
- LTXREWYXXSTFRX-QGZVFWFLSA-N Linagliptin Chemical compound N=1C=2N(C)C(=O)N(CC=3N=C4C=CC=CC4=C(C)N=3)C(=O)C=2N(CC#CC)C=1N1CCC[C@@H](N)C1 LTXREWYXXSTFRX-QGZVFWFLSA-N 0.000 description 1
- 229960002397 Linagliptin Drugs 0.000 description 1
- 206010024627 Liposarcoma Diseases 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- YROQEQPFUCPDCP-UHFFFAOYSA-N Losoxantrone Chemical compound OCCNCCN1N=C2C3=CC=CC(O)=C3C(=O)C3=C2C1=CC=C3NCCNCCO YROQEQPFUCPDCP-UHFFFAOYSA-N 0.000 description 1
- 229950008745 Losoxantrone Drugs 0.000 description 1
- 210000004072 Lung Anatomy 0.000 description 1
- 229940087857 Lupron Drugs 0.000 description 1
- RVFGKBWWUQOIOU-NDEPHWFRSA-N Lurtotecan Chemical compound O=C([C@]1(O)CC)OCC(C(N2CC3=4)=O)=C1C=C2C3=NC1=CC=2OCCOC=2C=C1C=4CN1CCN(C)CC1 RVFGKBWWUQOIOU-NDEPHWFRSA-N 0.000 description 1
- 229950002654 Lurtotecan Drugs 0.000 description 1
- 210000003171 Lymphocytes, Tumor-Infiltrating Anatomy 0.000 description 1
- 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
- 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
- 108010085169 Lysine Carboxypeptidase Proteins 0.000 description 1
- 102100010544 MALT1 Human genes 0.000 description 1
- 101710042185 MCT7 Proteins 0.000 description 1
- 102100013126 METAP1 Human genes 0.000 description 1
- 101710039852 METAP1 Proteins 0.000 description 1
- 102100016477 METAP2 Human genes 0.000 description 1
- 101710012506 METAP2 Proteins 0.000 description 1
- 102100004973 MMP15 Human genes 0.000 description 1
- 101700033206 MMP15 Proteins 0.000 description 1
- 102100018198 MMP16 Human genes 0.000 description 1
- 101700013081 MMP16 Proteins 0.000 description 1
- 102100012744 MMP21 Human genes 0.000 description 1
- 102100012741 MMP23B Human genes 0.000 description 1
- 108091006994 MMP23B Proteins 0.000 description 1
- 102100012743 MMP24 Human genes 0.000 description 1
- 101700042912 MMP24 Proteins 0.000 description 1
- 101700026411 MMP25 Proteins 0.000 description 1
- 102100014895 MMP27 Human genes 0.000 description 1
- 101700046621 MMP27 Proteins 0.000 description 1
- 102100014896 MMP28 Human genes 0.000 description 1
- 101700054191 MMP28 Proteins 0.000 description 1
- 102000008904 MPN domain Human genes 0.000 description 1
- 108050000834 MPN domain Proteins 0.000 description 1
- 102100018546 MYSM1 Human genes 0.000 description 1
- 108060005975 MYSM1 Proteins 0.000 description 1
- WKPWGQKGSOKKOO-RSFHAFMBSA-N Maitansine Chemical compound CO[C@@H]([C@@]1(O)C[C@](OC(=O)N1)([C@H]([C@@H]1O[C@@]1(C)[C@@H](OC(=O)[C@H](C)N(C)C(C)=O)CC(=O)N1C)C)[H])\C=C\C=C(C)\CC2=CC(OC)=C(Cl)C1=C2 WKPWGQKGSOKKOO-RSFHAFMBSA-N 0.000 description 1
- 229950001474 Maitansine Drugs 0.000 description 1
- MQXVYODZCMMZEM-ZYUZMQFOSA-N Mannomustine Chemical compound ClCCNC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CNCCCl MQXVYODZCMMZEM-ZYUZMQFOSA-N 0.000 description 1
- 229940099262 Marinol Drugs 0.000 description 1
- 210000000138 Mast Cells Anatomy 0.000 description 1
- 229960004296 Megestrol Acetate Drugs 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- 241001342637 Mesophylla Species 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 108090000192 Methionyl aminopeptidases Proteins 0.000 description 1
- VFKZTMPDYBFSTM-KVTDHHQDSA-N Mitobronitol Chemical compound BrC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CBr VFKZTMPDYBFSTM-KVTDHHQDSA-N 0.000 description 1
- 108010063698 Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein Proteins 0.000 description 1
- 210000002027 Muscle, Skeletal Anatomy 0.000 description 1
- 229960000951 Mycophenolic Acid Drugs 0.000 description 1
- UWYXLGUQQFPJRI-UHFFFAOYSA-N N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.CC1=CC=C(S(O)(=O)=O)C=C1.O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 UWYXLGUQQFPJRI-UHFFFAOYSA-N 0.000 description 1
- DYMRYCZRMAHYKE-UHFFFAOYSA-N N-diazonitramide Chemical group [O-][N+](=O)N=[N+]=[N-] DYMRYCZRMAHYKE-UHFFFAOYSA-N 0.000 description 1
- XGXNTJHZPBRBHJ-UHFFFAOYSA-N N-phenylpyrimidin-2-amine Chemical class N=1C=CC=NC=1NC1=CC=CC=C1 XGXNTJHZPBRBHJ-UHFFFAOYSA-N 0.000 description 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
- 102100007527 NCLN Human genes 0.000 description 1
- 101700033979 NCLN Proteins 0.000 description 1
- 102100007907 NCR1 Human genes 0.000 description 1
- 101710009580 NCR1 Proteins 0.000 description 1
- 102100007909 NCR2 Human genes 0.000 description 1
- 101710009579 NCR2 Proteins 0.000 description 1
- 102100007908 NCR3 Human genes 0.000 description 1
- 101710009588 NCR3 Proteins 0.000 description 1
- 102100017247 NEK2 Human genes 0.000 description 1
- 101700042931 NEK2 Proteins 0.000 description 1
- 229940086322 Navelbine Drugs 0.000 description 1
- 108010008267 Nerve Growth Factors Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 210000000944 Nerve Tissue Anatomy 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 229940085033 Nolvadex Drugs 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N OBO Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 101700035881 OTUD1 Proteins 0.000 description 1
- 102100019757 OTUD3 Human genes 0.000 description 1
- 101700086315 OTUD3 Proteins 0.000 description 1
- 229920000272 Oligonucleotide Polymers 0.000 description 1
- 229950011093 Onapristone Drugs 0.000 description 1
- 102100004038 PAN2 Human genes 0.000 description 1
- 108060005927 PAN2 Proteins 0.000 description 1
- 101700011774 PEPD Proteins 0.000 description 1
- 102100002874 PEPD Human genes 0.000 description 1
- 102100015416 PGPEP1 Human genes 0.000 description 1
- 101710027262 PKD1L3 Proteins 0.000 description 1
- 102100004368 PKD1L3 Human genes 0.000 description 1
- 102100012896 PLGLB1 Human genes 0.000 description 1
- 101710014095 PLGLB1 Proteins 0.000 description 1
- 102100004012 PPAT Human genes 0.000 description 1
- 102100007893 PRKCA Human genes 0.000 description 1
- 101710038828 PRKCA Proteins 0.000 description 1
- 102100000553 PRSS12 Human genes 0.000 description 1
- 101710043612 PRSS33 Proteins 0.000 description 1
- 102100020213 PRSS35 Human genes 0.000 description 1
- 101710043605 PRSS35 Proteins 0.000 description 1
- 102100012536 PRSS36 Human genes 0.000 description 1
- 101710040324 PRSS36 Proteins 0.000 description 1
- 102100003245 PSMA1 Human genes 0.000 description 1
- 101700083322 PSMA3 Proteins 0.000 description 1
- 102100009770 PSMA3 Human genes 0.000 description 1
- 101700065052 PSMA4 Proteins 0.000 description 1
- 102100016936 PSMA4 Human genes 0.000 description 1
- 101710033517 PSMA6 Proteins 0.000 description 1
- 102100020297 PSMA6 Human genes 0.000 description 1
- 101710033555 PSMB2 Proteins 0.000 description 1
- 102100018209 PSMB2 Human genes 0.000 description 1
- 101710033558 PSMB3 Proteins 0.000 description 1
- 102100009997 PSMB3 Human genes 0.000 description 1
- 101710033547 PSMB6 Proteins 0.000 description 1
- 102100010838 PSMB6 Human genes 0.000 description 1
- 101710033538 PSMB7 Proteins 0.000 description 1
- 102100018329 PSMB7 Human genes 0.000 description 1
- 102100017982 PSMD7 Human genes 0.000 description 1
- 101700054879 PSMD7 Proteins 0.000 description 1
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N PUROMYCIN Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 1
- 229950010131 PUROMYCIN Drugs 0.000 description 1
- WRUUGTRCQOWXEG-UHFFFAOYSA-N Pamidronic acid Chemical compound NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 description 1
- 210000000496 Pancreas Anatomy 0.000 description 1
- 102000016387 Pancreatic Elastase Human genes 0.000 description 1
- 108010067372 Pancreatic Elastase Proteins 0.000 description 1
- 208000004019 Papillary Adenocarcinoma Diseases 0.000 description 1
- 229960002340 Pentostatin Drugs 0.000 description 1
- FPVKHBSQESCIEP-JQCXWYLXSA-N Pentostatin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC[C@H]2O)=C2N=C1 FPVKHBSQESCIEP-JQCXWYLXSA-N 0.000 description 1
- 108010067902 Peptide Library Proteins 0.000 description 1
- RDOWQLZANAYVLL-UHFFFAOYSA-N Phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Chemical compound C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 229950000688 Phenothiazine Drugs 0.000 description 1
- TZMSYXZUNZXBOL-UHFFFAOYSA-N Phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
- 241000070023 Phoenicopterus roseus Species 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N Phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- NJBFOOCLYDNZJN-UHFFFAOYSA-N Pipobroman Chemical compound BrCCC(=O)N1CCN(C(=O)CCBr)CC1 NJBFOOCLYDNZJN-UHFFFAOYSA-N 0.000 description 1
- 210000004011 Plasma Cells Anatomy 0.000 description 1
- 208000007452 Plasmacytoma Diseases 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N Prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- CPTBDICYNRMXFX-UHFFFAOYSA-N Procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
- 229940087463 Proleukin Drugs 0.000 description 1
- 210000002307 Prostate Anatomy 0.000 description 1
- 102000017850 Proteasome subunit alpha2 Human genes 0.000 description 1
- 108050007073 Proteasome subunit alpha2 Proteins 0.000 description 1
- 102000001593 Proteasome subunit alpha5 Human genes 0.000 description 1
- 108050009823 Proteasome subunit alpha5 Proteins 0.000 description 1
- 108050007094 Proteasome subunit alpha6 Proteins 0.000 description 1
- 101800001072 Protein 1A Proteins 0.000 description 1
- 102000017975 Protein C Human genes 0.000 description 1
- 229960000856 Protein C Drugs 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010009341 Protein-Serine-Threonine Kinases Proteins 0.000 description 1
- 102000009516 Protein-Serine-Threonine Kinases Human genes 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N Pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N Pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
- 108090000919 Pyroglutamyl-Peptidase I Proteins 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N Quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- XSCHRSMBECNVNS-UHFFFAOYSA-N Quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 1
- 108020004532 RAS Proteins 0.000 description 1
- 102100015132 RNPEP Human genes 0.000 description 1
- 102100017713 RNPEPL1 Human genes 0.000 description 1
- 101710011110 RP373 Proteins 0.000 description 1
- GZUITABIAKMVPG-UHFFFAOYSA-N Raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 1
- 229960004622 Raloxifene Drugs 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- BXNMTOQRYBFHNZ-UHFFFAOYSA-N Resiquimod Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CC(C)(C)O)C3=C(N)N=C21 BXNMTOQRYBFHNZ-UHFFFAOYSA-N 0.000 description 1
- 229950010550 Resiquimod Drugs 0.000 description 1
- IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 description 1
- 229950004892 Rodorubicin Drugs 0.000 description 1
- 101710026336 S5 Proteins 0.000 description 1
- 102100014586 SELPLG Human genes 0.000 description 1
- 101710023851 SELPLG Proteins 0.000 description 1
- 101700034670 SENP1 Proteins 0.000 description 1
- 102100000901 SENP1 Human genes 0.000 description 1
- 101700055362 SENP2 Proteins 0.000 description 1
- 102100000902 SENP2 Human genes 0.000 description 1
- 101700076793 SENP3 Proteins 0.000 description 1
- 102100001768 SENP3 Human genes 0.000 description 1
- 102100001774 SENP5 Human genes 0.000 description 1
- 101700085048 SENP5 Proteins 0.000 description 1
- 102100001773 SENP7 Human genes 0.000 description 1
- 101700006371 SENP7 Proteins 0.000 description 1
- 101700005866 SENP8 Proteins 0.000 description 1
- 102100001778 SENP8 Human genes 0.000 description 1
- 102100017640 SLAMF7 Human genes 0.000 description 1
- 101710030435 SLAMF7 Proteins 0.000 description 1
- 102100013400 STAMBP Human genes 0.000 description 1
- 101710035918 STAMBP Proteins 0.000 description 1
- 101700074681 STX2 Proteins 0.000 description 1
- 102100018831 SUPT16H Human genes 0.000 description 1
- 101710025445 SUPT16H Proteins 0.000 description 1
- 229960004937 Saxagliptin Drugs 0.000 description 1
- 101710033766 Segment-10 Proteins 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- 108010070144 Single-Chain Antibodies Proteins 0.000 description 1
- 102000005632 Single-Chain Antibodies Human genes 0.000 description 1
- MFFMDFFZMYYVKS-SECBINFHSA-N Sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 1
- 229940112726 Skelid Drugs 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 210000000278 Spinal Cord Anatomy 0.000 description 1
- 229950006315 Spirogermanium Drugs 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 206010041823 Squamous cell carcinoma Diseases 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical group [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 210000004243 Sweat Anatomy 0.000 description 1
- 230000017274 T cell anergy Effects 0.000 description 1
- 108091008153 T cell receptors Proteins 0.000 description 1
- BXFOFFBJRFZBQZ-QYWOHJEZSA-N T-2 mycotoxin Chemical compound C([C@@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@H]1[C@]3(COC(C)=O)C[C@@H](C(=C1)C)OC(=O)CC(C)C)O2 BXFOFFBJRFZBQZ-QYWOHJEZSA-N 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 102100018462 TASP1 Human genes 0.000 description 1
- 101700039252 TASP1 Proteins 0.000 description 1
- 102100008336 TG Human genes 0.000 description 1
- 108060003967 TIM Proteins 0.000 description 1
- 108060008273 TIMELESS Proteins 0.000 description 1
- 102100001073 TMPRSS13 Human genes 0.000 description 1
- 101710044652 TMPRSS13 Proteins 0.000 description 1
- 102100009508 TMPRSS15 Human genes 0.000 description 1
- 102100011827 TMPRSS2 Human genes 0.000 description 1
- 101710044694 TMPRSS2 Proteins 0.000 description 1
- 101710044695 TMPRSS3 Proteins 0.000 description 1
- 102100001068 TMPRSS5 Human genes 0.000 description 1
- 101710044692 TMPRSS5 Proteins 0.000 description 1
- 101710030862 TNFRSF13C Proteins 0.000 description 1
- 102100009743 TNFRSF13C Human genes 0.000 description 1
- 101710038601 TNFRSF14 Proteins 0.000 description 1
- 101710038524 TNFRSF1B Proteins 0.000 description 1
- 102100003105 TNFRSF1B Human genes 0.000 description 1
- 102100012560 TPSB2 Human genes 0.000 description 1
- 101710037984 TPSB2 Proteins 0.000 description 1
- 102100009949 TPSD1 Human genes 0.000 description 1
- 101700078844 TPSD1 Proteins 0.000 description 1
- 102100009950 TPSG1 Human genes 0.000 description 1
- 101710037935 TPSG1 Proteins 0.000 description 1
- AYUNIORJHRXIBJ-TXHRRWQRSA-N Tanespimycin Chemical compound N1C(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC2=C(NCC=C)C(=O)C=C1C2=O AYUNIORJHRXIBJ-TXHRRWQRSA-N 0.000 description 1
- WFWLQNSHRPWKFK-ZCFIWIBFSA-N Tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 description 1
- 229960001278 Teniposide Drugs 0.000 description 1
- KLBSRSYHIIAQTG-PZICIZFRSA-N Tenuazonic acid Chemical compound CC[C@H](C)[C@@H]1NC(=O)C(C(C)=O)C1=O KLBSRSYHIIAQTG-PZICIZFRSA-N 0.000 description 1
- 229940033529 Tetrahydrocannabinol Drugs 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N Tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- 229960005454 Thioguanine Drugs 0.000 description 1
- 229960002175 Thyroglobulin Drugs 0.000 description 1
- 108010034949 Thyroglobulin Proteins 0.000 description 1
- 210000001685 Thyroid Gland Anatomy 0.000 description 1
- DKJJVAGXPKPDRL-UHFFFAOYSA-N Tiludronic acid Chemical compound OP(O)(=O)C(P(O)(O)=O)SC1=CC=C(Cl)C=C1 DKJJVAGXPKPDRL-UHFFFAOYSA-N 0.000 description 1
- 102000003978 Tissue plasminogen activator Human genes 0.000 description 1
- 108090000373 Tissue plasminogen activator Proteins 0.000 description 1
- 239000000365 Topoisomerase I Inhibitor Substances 0.000 description 1
- 210000003437 Trachea Anatomy 0.000 description 1
- 206010044334 Trance Diseases 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 229950001353 Tretamine Drugs 0.000 description 1
- 229960001727 Tretinoin Drugs 0.000 description 1
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 1
- NOYPYLRCIDNJJB-UHFFFAOYSA-N Trimetrexate Chemical compound COC1=C(OC)C(OC)=CC(NCC=2C(=C3C(N)=NC(N)=NC3=CC=2)C)=C1 NOYPYLRCIDNJJB-UHFFFAOYSA-N 0.000 description 1
- 229960001099 Trimetrexate Drugs 0.000 description 1
- FYAMXEPQQLNQDM-UHFFFAOYSA-N Tris(1-aziridinyl)phosphine oxide Chemical compound C1CN1P(N1CC1)(=O)N1CC1 FYAMXEPQQLNQDM-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 102000003390 Tumor Necrosis Factors Human genes 0.000 description 1
- 108060008682 Tumor Necrosis Factors Proteins 0.000 description 1
- NMUSYJAQQFHJEW-KVTDHHQDSA-N U-18,496 Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 1
- 229950009811 UBENIMEX Drugs 0.000 description 1
- 101700074507 UFSP1 Proteins 0.000 description 1
- 102100011564 UFSP1 Human genes 0.000 description 1
- 101700012042 UFSP2 Proteins 0.000 description 1
- 102100008454 UFSP2 Human genes 0.000 description 1
- 101710008831 UQCRC1 Proteins 0.000 description 1
- 102100013168 UQCRC1 Human genes 0.000 description 1
- 102100013178 UQCRC2 Human genes 0.000 description 1
- 101710008836 UQCRC2 Proteins 0.000 description 1
- 102100011110 USP10 Human genes 0.000 description 1
- 108060005929 USP10 Proteins 0.000 description 1
- 102100017881 USP11 Human genes 0.000 description 1
- 101700043628 USP11 Proteins 0.000 description 1
- 102100017883 USP12 Human genes 0.000 description 1
- 101700045440 USP12 Proteins 0.000 description 1
- 102100008457 USP13 Human genes 0.000 description 1
- 101700047220 USP13 Proteins 0.000 description 1
- 102100008462 USP14 Human genes 0.000 description 1
- 101710009617 USP14 Proteins 0.000 description 1
- 102100008465 USP15 Human genes 0.000 description 1
- 101710009615 USP15 Proteins 0.000 description 1
- 102100005064 USP16 Human genes 0.000 description 1
- 108060005932 USP16 Proteins 0.000 description 1
- 102100005067 USP18 Human genes 0.000 description 1
- 101710009614 USP18 Proteins 0.000 description 1
- 102100011609 USP19 Human genes 0.000 description 1
- 101710009618 USP19 Proteins 0.000 description 1
- 102100007929 USP2 Human genes 0.000 description 1
- 108060005937 USP2 Proteins 0.000 description 1
- 102100011577 USP20 Human genes 0.000 description 1
- 101710010222 USP20 Proteins 0.000 description 1
- 102100002747 USP21 Human genes 0.000 description 1
- 108060005935 USP21 Proteins 0.000 description 1
- 102100002748 USP22 Human genes 0.000 description 1
- 101700010481 USP22 Proteins 0.000 description 1
- 102100002743 USP24 Human genes 0.000 description 1
- 101710010219 USP24 Proteins 0.000 description 1
- 102100005734 USP25 Human genes 0.000 description 1
- 101710010220 USP25 Proteins 0.000 description 1
- 102100005732 USP26 Human genes 0.000 description 1
- 101700065442 USP26 Proteins 0.000 description 1
- 102100005736 USP29 Human genes 0.000 description 1
- 101710010227 USP29 Proteins 0.000 description 1
- 102100007933 USP31 Human genes 0.000 description 1
- 101710010106 USP31 Proteins 0.000 description 1
- 102100007931 USP32 Human genes 0.000 description 1
- 101710010109 USP32 Proteins 0.000 description 1
- 102100015868 USP34 Human genes 0.000 description 1
- 101710010117 USP34 Proteins 0.000 description 1
- 102100015872 USP36 Human genes 0.000 description 1
- 101710010112 USP36 Proteins 0.000 description 1
- 102100015854 USP37 Human genes 0.000 description 1
- 101710010113 USP37 Proteins 0.000 description 1
- 102100017876 USP4 Human genes 0.000 description 1
- 108060005941 USP4 Proteins 0.000 description 1
- 102100015848 USP40 Human genes 0.000 description 1
- 101710010124 USP40 Proteins 0.000 description 1
- 102100015851 USP41 Human genes 0.000 description 1
- 101710010087 USP41 Proteins 0.000 description 1
- 102100015853 USP42 Human genes 0.000 description 1
- 101710010083 USP42 Proteins 0.000 description 1
- 102100011115 USP44 Human genes 0.000 description 1
- 108060005939 USP44 Proteins 0.000 description 1
- 102100011114 USP45 Human genes 0.000 description 1
- 101700075180 USP45 Proteins 0.000 description 1
- 102100017872 USP49 Human genes 0.000 description 1
- 101710010092 USP49 Proteins 0.000 description 1
- 102100002751 USP5 Human genes 0.000 description 1
- 101700023306 USP5 Proteins 0.000 description 1
- 102100002744 USP50 Human genes 0.000 description 1
- 101710010107 USP50 Proteins 0.000 description 1
- 102100002745 USP51 Human genes 0.000 description 1
- 101710010111 USP51 Proteins 0.000 description 1
- 102100002746 USP53 Human genes 0.000 description 1
- 101710010079 USP53 Proteins 0.000 description 1
- 102100002750 USP54 Human genes 0.000 description 1
- 101710010073 USP54 Proteins 0.000 description 1
- 102100002752 USP6 Human genes 0.000 description 1
- 101700066130 USP6 Proteins 0.000 description 1
- 102100011581 USP8 Human genes 0.000 description 1
- 101700064687 USP8 Proteins 0.000 description 1
- 102000001591 Ubiquitin specific peptidase 1 Human genes 0.000 description 1
- 108050009822 Ubiquitin specific peptidase 1 Proteins 0.000 description 1
- 102000001522 Ubiquitin-specific peptidase 38 Human genes 0.000 description 1
- 108050009759 Ubiquitin-specific peptidase 38 Proteins 0.000 description 1
- 210000003606 Umbilical Veins Anatomy 0.000 description 1
- 210000003932 Urinary Bladder Anatomy 0.000 description 1
- 206010046766 Uterine cancer Diseases 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 102100010125 VCPIP1 Human genes 0.000 description 1
- 101710004386 VCPIP1 Proteins 0.000 description 1
- 229960004355 Vindesine Drugs 0.000 description 1
- GBABOYUKABKIAF-GHYRFKGUSA-N Vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 description 1
- 206010047802 Waldenstrom's macroglobulinaemias Diseases 0.000 description 1
- 208000008383 Wilms Tumor Diseases 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N Xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 229940053867 Xeloda Drugs 0.000 description 1
- AOCCBINRVIKJHY-UHFFFAOYSA-N Yamafur Chemical compound CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O AOCCBINRVIKJHY-UHFFFAOYSA-N 0.000 description 1
- 229940002005 Zometa Drugs 0.000 description 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N [(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 1
- NUKCGLDCWQXYOQ-UHFFFAOYSA-N [3-[4-(3-methylsulfonyloxypropanoyl)piperazin-1-yl]-3-oxopropyl] methanesulfonate Chemical compound CS(=O)(=O)OCCC(=O)N1CCN(C(=O)CCOS(C)(=O)=O)CC1 NUKCGLDCWQXYOQ-UHFFFAOYSA-N 0.000 description 1
- ZYJKONDZYOWOHE-UHFFFAOYSA-N [4-amino-3-(hydroxymethyl)phenyl]methanol Chemical compound NC1=CC=C(CO)C=C1CO ZYJKONDZYOWOHE-UHFFFAOYSA-N 0.000 description 1
- AIWRTTMUVOZGPW-HSPKUQOVSA-N abarelix Chemical compound C([C@@H](C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 AIWRTTMUVOZGPW-HSPKUQOVSA-N 0.000 description 1
- 108010023617 abarelix Proteins 0.000 description 1
- 229960002184 abarelix Drugs 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 201000005510 acute lymphocytic leukemia Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000003044 adaptive Effects 0.000 description 1
- 230000033289 adaptive immune response Effects 0.000 description 1
- 230000001464 adherent Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000001919 adrenal Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N aldehydo-D-arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- 229960001667 alogliptin Drugs 0.000 description 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 229960000473 altretamine Drugs 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 229960002749 aminolevulinic acid Drugs 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N aminolevulinic acid Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- 108090000449 aminopeptidase B Proteins 0.000 description 1
- 101700084907 ampp Proteins 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 201000003076 angiosarcoma Diseases 0.000 description 1
- 230000002280 anti-androgenic Effects 0.000 description 1
- 230000003388 anti-hormone Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000003418 antiprogestin Substances 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 101710043144 apeI Proteins 0.000 description 1
- 125000000511 arginine group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 239000003886 aromatase inhibitor Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 108010072668 atezolizumab Proteins 0.000 description 1
- 230000003305 autocrine Effects 0.000 description 1
- 108010010826 avelumab Proteins 0.000 description 1
- 235000020127 ayran Nutrition 0.000 description 1
- 125000003725 azepanyl group Chemical group 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- ICCBZGUDUOMNOF-UHFFFAOYSA-N azidoamine Chemical compound NN=[N+]=[N-] ICCBZGUDUOMNOF-UHFFFAOYSA-N 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 150000004663 bisphosphonates Chemical class 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- MPBVHIBUJCELCL-UHFFFAOYSA-N bondronat Chemical compound CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O MPBVHIBUJCELCL-UHFFFAOYSA-N 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 201000010983 breast ductal carcinoma Diseases 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229960002092 busulfan Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 108090000007 carboxypeptidase M Proteins 0.000 description 1
- 229960003261 carmofur Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004709 cell invasion Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Chemical group 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- QZHPTGXQGDFGEN-UHFFFAOYSA-N chromene Chemical compound C1=CC=C2C=C[CH]OC2=C1 QZHPTGXQGDFGEN-UHFFFAOYSA-N 0.000 description 1
- LJAOOBNHPFKCDR-UHFFFAOYSA-K chromium(3+) trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cr+3] LJAOOBNHPFKCDR-UHFFFAOYSA-K 0.000 description 1
- 201000006934 chronic myeloid leukemia Diseases 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 108010072917 class-I restricted T cell-associated molecule Proteins 0.000 description 1
- 108010022822 collapsin response mediator protein-2 Proteins 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000002860 competitive Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000000139 costimulatory Effects 0.000 description 1
- 108090000711 cruzipain Proteins 0.000 description 1
- 108010006226 cryptophycin Proteins 0.000 description 1
- 108010089438 cryptophycin 1 Proteins 0.000 description 1
- 108010090203 cryptophycin 8 Proteins 0.000 description 1
- 125000006448 cycloalkyl cycloalkyl group Chemical group 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 229960003901 dacarbazine Drugs 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 108091022040 dihydropyrimidinase Proteins 0.000 description 1
- 230000003292 diminished Effects 0.000 description 1
- 201000008325 diseases of cellular proliferation Diseases 0.000 description 1
- 231100000371 dose-limiting toxicity Toxicity 0.000 description 1
- 108010016436 durvalumab Proteins 0.000 description 1
- 229950006700 edatrexate Drugs 0.000 description 1
- 210000003162 effector T lymphocyte Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 108091010081 enhancer binding proteins Proteins 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 102000017256 epidermal growth factor-activated receptor activity proteins Human genes 0.000 description 1
- 108040009258 epidermal growth factor-activated receptor activity proteins Proteins 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 150000002170 ethers Chemical group 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229960000255 exemestane Drugs 0.000 description 1
- 108091005632 farnesylated proteins Proteins 0.000 description 1
- 201000008808 fibrosarcoma Diseases 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 229940044658 gallium nitrate Drugs 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 229960005277 gemcitabine Drugs 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000003899 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 101710031799 gp63-C1 Proteins 0.000 description 1
- 108010022683 guanidinobenzoate esterase Proteins 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000008064 heavy chain disease Diseases 0.000 description 1
- 201000002222 hemangioblastoma Diseases 0.000 description 1
- 150000002390 heteroarenes Chemical class 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- XPXMKIXDFWLRAA-UHFFFAOYSA-N hydrazinide Chemical compound [NH-]N XPXMKIXDFWLRAA-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 1
- 229960001330 hydroxycarbamide Drugs 0.000 description 1
- VSNHCAURESNICA-UHFFFAOYSA-N hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 1
- 229940027318 hydroxyurea Drugs 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 150000002466 imines Chemical group 0.000 description 1
- 229960002751 imiquimod Drugs 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000001771 impaired Effects 0.000 description 1
- 229950008097 improsulfan Drugs 0.000 description 1
- 230000002757 inflammatory Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000004073 interleukin-2 production Effects 0.000 description 1
- 229940079867 intestinal antiinfectives Sulfonamides Drugs 0.000 description 1
- 229910052740 iodine Chemical group 0.000 description 1
- 239000011630 iodine Chemical group 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 229960005386 ipilimumab Drugs 0.000 description 1
- 229960004768 irinotecan Drugs 0.000 description 1
- 108010076401 isopeptidase Proteins 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 108010024383 kallikrein 4 Proteins 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229960001320 lapatinib ditosylate Drugs 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 101710013613 let-413 Proteins 0.000 description 1
- 230000021633 leukocyte mediated immunity Effects 0.000 description 1
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
- RGLRXNKKBLIBQS-XNHQSDQCSA-N leuprolide acetate Chemical compound CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 RGLRXNKKBLIBQS-XNHQSDQCSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 101710028320 ltah-1.1 Proteins 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 230000001926 lymphatic Effects 0.000 description 1
- 201000000564 macroglobulinemia Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229950008612 mannomustine Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000003071 memory T lymphocyte Anatomy 0.000 description 1
- 230000003340 mental Effects 0.000 description 1
- 108091007013 meprins Proteins 0.000 description 1
- 230000002503 metabolic Effects 0.000 description 1
- AWIJRPNMLHPLNC-UHFFFAOYSA-M methanethioate Chemical compound [O-]C=S AWIJRPNMLHPLNC-UHFFFAOYSA-M 0.000 description 1
- 230000003278 mimic Effects 0.000 description 1
- 229960005485 mitobronitol Drugs 0.000 description 1
- 108010042046 mitochondrial processing peptidase Proteins 0.000 description 1
- ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
- 108060005018 mobB Proteins 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 201000006894 monocytic leukemia Diseases 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- 229940113083 morpholine Drugs 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 201000009251 multiple myeloma Diseases 0.000 description 1
- 230000000869 mutational Effects 0.000 description 1
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 201000004458 myoma Diseases 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000005445 natural product Substances 0.000 description 1
- 229930014626 natural products Natural products 0.000 description 1
- 201000008026 nephroblastoma Diseases 0.000 description 1
- 210000004255 neuroglia Anatomy 0.000 description 1
- 239000003900 neurotrophic factor Substances 0.000 description 1
- 108010037733 neurotrypsin Proteins 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- MAZYQGHSTXUZJF-ZBRHGPMOSA-N nogalamycin Chemical compound CO[C@@H]1[C@@](O)(C)[C@@H](OC)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=C(O)C=C4[C@]5(C)C[C@H](C[C@@H](O5)CC4=C3C3=O)N(C)C)=C3C=C2[C@@H](C(=O)OC)[C@@](C)(O)C1 MAZYQGHSTXUZJF-ZBRHGPMOSA-N 0.000 description 1
- 229950009266 nogalamycin Drugs 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 201000010133 oligodendroglioma Diseases 0.000 description 1
- 229940005938 ophthalmologic antiinfectives Sulfonamides Drugs 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229940046231 pamidronate Drugs 0.000 description 1
- 201000010198 papillary carcinoma Diseases 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- WBXPDJSOTKVWSJ-ZDUSSCGKSA-N pemetrexed Chemical compound C=1NC=2NC(N)=NC(=O)C=2C=1CCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 WBXPDJSOTKVWSJ-ZDUSSCGKSA-N 0.000 description 1
- 229960005079 pemetrexed Drugs 0.000 description 1
- 230000000149 penetrating Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 101700023892 pepA1 Proteins 0.000 description 1
- 101700006434 pept-1 Proteins 0.000 description 1
- 108010072633 peptidase 7 Proteins 0.000 description 1
- 125000001151 peptidyl group Chemical group 0.000 description 1
- 230000000737 periodic Effects 0.000 description 1
- 230000002085 persistent Effects 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- GYHHZMUNWLCUAH-UHFFFAOYSA-N phenothiazine Chemical compound C1=CC=C2[N]C3=CC=CC=C3SC2=C1 GYHHZMUNWLCUAH-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000000865 phosphorylative Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229960000952 pipobroman Drugs 0.000 description 1
- 229950001100 piposulfan Drugs 0.000 description 1
- 229960001221 pirarubicin Drugs 0.000 description 1
- 108010025221 plasma protein Z Proteins 0.000 description 1
- 150000003057 platinum Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 108010048507 poliovirus receptor Proteins 0.000 description 1
- 108091008117 polyclonal antibodies Proteins 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 230000004492 positive regulation of T cell proliferation Effects 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000770 pro-inflamatory Effects 0.000 description 1
- 229960000624 procarbazine Drugs 0.000 description 1
- 230000003623 progesteronic Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002062 proliferating Effects 0.000 description 1
- 108010066823 proline dipeptidase Proteins 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 230000007055 protein processing involved in protein targeting to mitochondrion Effects 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 108020001180 rasD Proteins 0.000 description 1
- 229960000460 razoxane Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 201000010174 renal carcinoma Diseases 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 230000002207 retinal Effects 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229960000759 risedronic acid Drugs 0.000 description 1
- 108010033693 saxagliptin Proteins 0.000 description 1
- 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 229960004034 sitagliptin Drugs 0.000 description 1
- 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical group [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- FQZYTYWMLGAPFJ-OQKDUQJOSA-N tamoxifen citrate Chemical compound [H+].[H+].[H+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 FQZYTYWMLGAPFJ-OQKDUQJOSA-N 0.000 description 1
- 229960001674 tegafur Drugs 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- DUYAAUVXQSMXQP-UHFFFAOYSA-M thioacetate Chemical compound CC([S-])=O DUYAAUVXQSMXQP-UHFFFAOYSA-M 0.000 description 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 229940026752 topical Sulfonamides Drugs 0.000 description 1
- 230000002103 transcriptional Effects 0.000 description 1
- 102000035402 transmembrane proteins Human genes 0.000 description 1
- 108091005683 transmembrane proteins Proteins 0.000 description 1
- LXZZYRPGZAFOLE-UHFFFAOYSA-L transplatin Chemical compound [H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H] LXZZYRPGZAFOLE-UHFFFAOYSA-L 0.000 description 1
- IUCJMVBFZDHPDX-UHFFFAOYSA-N tretamine Chemical compound C1CN1C1=NC(N2CC2)=NC(N2CC2)=N1 IUCJMVBFZDHPDX-UHFFFAOYSA-N 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 150000003327 trichothecene derivatives Chemical class [H][C@]12O[C@]3([H])[C@H]([*])[C@@H]([*])[C@@](C)(C33CO3)C1(C[*])C([*])C([*])C(C)=C2 0.000 description 1
- 229930013292 trichothecenes Natural products 0.000 description 1
- 239000011778 trisodium citrate Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- 230000000381 tumorigenic Effects 0.000 description 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 description 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 description 1
- 229940121358 tyrosine kinase inhibitors Drugs 0.000 description 1
- 150000003668 tyrosines Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002525 vasculotropin inhibitor Substances 0.000 description 1
- 230000000982 vasogenic Effects 0.000 description 1
- 229960001254 vildagliptin Drugs 0.000 description 1
- KDQAABAKXDWYSZ-JKDPCDLQSA-N vincaleukoblastine sulfate Chemical compound OS(O)(=O)=O.C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 KDQAABAKXDWYSZ-JKDPCDLQSA-N 0.000 description 1
- 229960002066 vinorelbine Drugs 0.000 description 1
- CILBMBUYJCWATM-IJDPFCGHSA-N vinorelbine L-tartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC CILBMBUYJCWATM-IJDPFCGHSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- MNFORVFSTILPAW-UHFFFAOYSA-N Β-Lactam Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862680300P | 2018-06-04 | 2018-06-04 | |
US62/680,300 | 2018-06-04 | ||
PCT/US2019/035374 WO2019236567A2 (fr) | 2018-06-04 | 2019-06-04 | Conjugué médicament-liant activé par un micro-environnement tumoral et utilisations associées |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021527042A JP2021527042A (ja) | 2021-10-11 |
JPWO2019236567A5 true JPWO2019236567A5 (fr) | 2022-06-01 |
Family
ID=68769932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020567774A Pending JP2021527042A (ja) | 2018-06-04 | 2019-06-04 | 腫瘍微小環境活性化薬物・結合剤コンジュゲート、及びそれに関連する使用 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20210353652A1 (fr) |
EP (1) | EP3801634A4 (fr) |
JP (1) | JP2021527042A (fr) |
KR (1) | KR20210016372A (fr) |
CN (1) | CN112601554A (fr) |
AU (1) | AU2019282150A1 (fr) |
CA (1) | CA3101640A1 (fr) |
IL (2) | IL279133B1 (fr) |
SG (1) | SG11202010890PA (fr) |
TW (1) | TWI834673B (fr) |
WO (1) | WO2019236567A2 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230149857A (ko) | 2016-07-07 | 2023-10-27 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 항체-애쥬번트 접합체 |
US11583516B2 (en) | 2016-09-07 | 2023-02-21 | Trustees Of Tufts College | Dash inhibitors, and uses related thereto |
EP3937984A1 (fr) | 2019-03-15 | 2022-01-19 | Bolt Biotherapeutics, Inc. | Immunoconjugués ciblant le her2 |
TW202110482A (zh) * | 2019-05-24 | 2021-03-16 | 日商糖鎖工學研究所股份有限公司 | 新穎的人工蛋白質觸媒 |
TW202120500A (zh) | 2019-08-02 | 2021-06-01 | 美商梅爾莎納醫療公司 | 干擾素基因刺激蛋白(sting)激動劑化合物及用途 |
TW202221030A (zh) * | 2020-07-30 | 2022-06-01 | 英商阿法克塔生命科學有限公司 | 血清白蛋白結合多肽 |
TW202221031A (zh) * | 2020-07-30 | 2022-06-01 | 英商阿法克塔生命科學有限公司 | 血清半衰期延長之pd-l1抑制多肽 |
US20230390409A1 (en) | 2020-10-30 | 2023-12-07 | Avacta Life Sciences Limited | Fap-activated serum extended half-life therapeutic conjugates |
EP4237011A1 (fr) * | 2020-10-30 | 2023-09-06 | Avacta Life Sciences Limited | Conjugués thérapeutiques à demi-vie sérique étendue activés par enzyme |
WO2022133288A1 (fr) | 2020-12-17 | 2022-06-23 | Trustees Of Tufts College | Radiothéranostiques activés par fap et utilisations associées |
WO2022234003A1 (fr) | 2021-05-07 | 2022-11-10 | Avacta Life Sciences Limited | Polypeptides se liant à cd33 avec protéine stefin a |
CN113648429B (zh) * | 2021-07-06 | 2023-11-10 | 中山大学 | 靶向肿瘤周围细胞激活免疫的聚合物及其制备方法与应用 |
WO2023057946A1 (fr) | 2021-10-07 | 2023-04-13 | Avacta Life Sciences Limited | Polypeptides sériques de liaison pd-l1 prolongés à demi-vie |
TW202334196A (zh) | 2021-10-07 | 2023-09-01 | 英商阿法克塔生命科學有限公司 | Pd-l1結合多肽 |
CN114404429B (zh) * | 2021-11-30 | 2023-06-30 | 重庆医科大学附属第二医院 | 一种纳米银修饰的单宁酸-铁网络的载药纳米复合物及其制备方法和逆转肿瘤耐药应用 |
KR20230121575A (ko) * | 2022-02-10 | 2023-08-18 | 주식회사 아피셀테라퓨틱스 | Cd40l에 특이적으로 결합하는 스테핀 a 단백질 변이체 및 이의 용도 |
WO2023218243A1 (fr) | 2022-05-12 | 2023-11-16 | Avacta Life Sciences Limited | Protéines de fusion de liaison lag-3/pd-l1 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0807065D0 (en) * | 2008-04-18 | 2008-05-21 | Univ Leeds | Novel scaffolds |
DK3024851T3 (en) * | 2013-07-25 | 2018-08-06 | Cytomx Therapeutics Inc | MULTI-SPECIFIC ANTIBODIES, MULTI-SPECIFICALLY ACTIVABLE ANTIBODIES, AND METHODS FOR USING IT |
WO2015114166A2 (fr) * | 2014-02-03 | 2015-08-06 | Philochem Ag | Conjugués médicamenteux ciblés |
SI3154594T1 (sl) * | 2014-06-13 | 2023-10-30 | Bach Biosciences, Llc | FAP-aktivirana terapevtska sredstva in z njimi povezane uporabe |
CN112587672A (zh) * | 2014-09-01 | 2021-04-02 | 博笛生物科技有限公司 | 用于***的抗-pd-l1结合物 |
TWI716362B (zh) * | 2014-10-14 | 2021-01-21 | 瑞士商諾華公司 | 針對pd-l1之抗體分子及其用途 |
JP2018518506A (ja) * | 2015-06-23 | 2018-07-12 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 大環状ベンゾジアゼピン二量体、その結合体の製造および使用 |
US20170158772A1 (en) * | 2015-12-07 | 2017-06-08 | Opi Vi - Ip Holdco Llc | Compositions of antibody construct - agonist conjugates and methods of use thereof |
MX2018015352A (es) * | 2016-06-10 | 2019-03-28 | Io Therapeutics Inc | Subtipos de receptores y compuestos retinoides y rexinoides de funcion selectiva combinados con moduladores inmunitarios para inmunoterapia contra el cancer. |
US11649285B2 (en) * | 2016-08-03 | 2023-05-16 | Bio-Techne Corporation | Identification of VSIG3/VISTA as a novel immune checkpoint and use thereof for immunotherapy |
US11583516B2 (en) * | 2016-09-07 | 2023-02-21 | Trustees Of Tufts College | Dash inhibitors, and uses related thereto |
WO2018053552A2 (fr) * | 2016-09-19 | 2018-03-22 | Cellerant Therapeutics, Inc. | Isoquinolidinobenzodiazépines |
GB201805963D0 (en) * | 2018-04-11 | 2018-05-23 | Avacta Life Sciences Ltd | PD-L1 Binding Affirmers and Uses Related Thereto |
US20220025061A1 (en) * | 2018-12-10 | 2022-01-27 | Bioxcel Therapeutics, Inc. | Combination therapies for treating disease using an innate immunity modifier and an ox40 agonist |
-
2019
- 2019-06-04 US US15/734,445 patent/US20210353652A1/en active Pending
- 2019-06-04 AU AU2019282150A patent/AU2019282150A1/en active Pending
- 2019-06-04 CN CN201980037469.3A patent/CN112601554A/zh active Pending
- 2019-06-04 IL IL279133A patent/IL279133B1/en unknown
- 2019-06-04 EP EP19814922.1A patent/EP3801634A4/fr active Pending
- 2019-06-04 TW TW108119354A patent/TWI834673B/zh active
- 2019-06-04 CA CA3101640A patent/CA3101640A1/fr active Pending
- 2019-06-04 IL IL311536A patent/IL311536A/en unknown
- 2019-06-04 WO PCT/US2019/035374 patent/WO2019236567A2/fr active Application Filing
- 2019-06-04 JP JP2020567774A patent/JP2021527042A/ja active Pending
- 2019-06-04 SG SG11202010890PA patent/SG11202010890PA/en unknown
- 2019-06-04 KR KR1020207035187A patent/KR20210016372A/ko unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI834673B (zh) | 經腫瘤微環境活化之藥物-結合子共軛物及與其相關之用途 | |
JP6913670B2 (ja) | キメラポリペプチドアセンブリーならびにそれを作製および使用する方法 | |
JP7068736B2 (ja) | Cd39と結合する抗体及びその使用 | |
JP7064234B2 (ja) | Sirpポリペプチド組成物および使用の方法 | |
TW202115128A (zh) | FLT3L-Fc融合蛋白及其使用方法 | |
CN111107866A (zh) | 用于免疫疗法的pde5组合物和方法 | |
TW202003014A (zh) | 結合pd-l1之親和體(affimer)及與其相關用途 | |
JPWO2019236567A5 (fr) | ||
ES2954851T3 (es) | Proteínas de unión multiespecífica que se unen a HER2, NKG2D y CD16, y métodos de uso | |
TW201932487A (zh) | 單域抗體-胞嘧啶脫氨酶融合蛋白及其製備方法、藥物組合物、及其用途 | |
EP3565898A1 (fr) | Cellules immunitaires car-vegfr-2 pour le traitement des cancers | |
WO2023020621A1 (fr) | Anticorps anti-ccr8 et leurs utilisations | |
JP2022518441A (ja) | ヒトcd137に結合する抗体の製剤およびその使用 | |
TW202332694A (zh) | 血清半衰期延長之pd-l1結合多肽 | |
WO2023164872A1 (fr) | Anticorps anti-cd39 et leur utilisation | |
RU2797536C2 (ru) | Варианты интерлейкина-18 и способы их применения | |
TW202334196A (zh) | Pd-l1結合多肽 | |
WO2022212668A1 (fr) | Procédés et compositions associés à des agonistes de tnfrsf25/dr3 | |
WO2023218243A1 (fr) | Protéines de fusion de liaison lag-3/pd-l1 | |
TW202417483A (zh) | 結合nkg2d、cd16及ceacam5之蛋白質 | |
WO2022234003A1 (fr) | Polypeptides se liant à cd33 avec protéine stefin a | |
EP4401776A1 (fr) | Protéines de fusion ciblant b7-h3 et leurs méthodes d'utilisation |